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ABSTRACT 
Allergic diseases have recently increased dramatically in the western world, now affecting 
about 30% of the Swedish population. The reasons for this increase are unclear, but some of 
the suspects are behavioral factors, such as stress and sleep. Problems with stress are also 
common today, and stress may change the set-points for the functioning of the body, for 
instance in the immune system. Sleep, on the other hand, is important for recuperation, and 
disturbed sleep acts a stressor in itself. Allergic patients often report stressful situations to 
cause allergic symptom exacerbations, and experience increased fatigue and disturbed sleep, 
especially when exposed to allergen. However, most aspects of the relations between stress, 
sleep, and allergy are still obscure. Therefore, this thesis aimed at increasing the 
understanding of these links. 
The thesis is based on three studies. The first is a quasi-experimental study of medical 
students with or without atopy, who were observed at two occasions, i.e. during a calmer 
study period and during a potentially stressful examination period (papers I & II). 
Assessments included blood sampling, lung function testing, and questionnaires and diaries 
on allergic and psychological symptoms and sleep. The results show that both atopic and 
non-atopic students increased ratings of stress and negative mood, had altered sleep patterns 
and changes in immune parameters, e.g. a marked increase in regulatory T-cells, during 
examination. Atopic participants also showed specific responses to stress, such as a shift 
towards T-helper 2 dominance, increased anxiety and disturbed sleep. Despite these 
changes, allergic symptoms were not affected. 
Paper III is based on a prospective epidemiological study, using parent report 
questionnaire data on aspects of disturbed sleep and allergy from the Twin Study of Child 
and Adolescent Development (TCHAD). Controlling for confounding effects of several 
factors, including gender, birth weight, and socioeconomic status, results from this study 
show that being overtired in childhood (age 8-9) predicts development of rhinitis in 
adolescence (age 13-14), but also that having asthma in childhood is predictive of becoming 
overtired in adolescence. Controlling for gender only, it also replicates findings from cross 
sectional studies of associations between allergy and disturbed sleep. 
The findings from paper I-III suggest that treatment of sleeping problems that are co-
morbid with e.g. allergies is an important issue. Therefore, paper IV is a randomized 
controlled trial of the efficacy of a CBT-based self-help treatment for insomnia with co-
morbid problems, including allergy. Assessments with questionnaires and sleep diaries took 
place at pre-treatment, post-treatment and three-month follow-up. The study shows that 
participants in the treatment groups display much improved sleep, and that the sleep of 
allergic individuals improved to the same extent as that of non-allergic individuals, despite 
co-existing allergic symptoms.  
In conclusion, stress is involved in allergy relevant immune changes, and the cumulative 
negative effects of stress (i.e. allostatic load) seem to be increased in atopic individuals as 
compared to non-atopics. The results thus speak for stress as a co-factor in an allergic 
reaction when exposed to allergen. Aspects of disturbed sleep may be involved in the 
development of allergy and vice versa, but disturbed sleep, also in individuals with allergy, 
can be treated efficiently with a CBT-based self-help treatment. The results of the thesis 
confirm a link between stress, sleep, and allergy, and suggest future studies to test if 
successful treatment of stress and sleep may decrease symptom expression or even diminish 
the risk for developing allergic disease.  
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1 INTRODUCTION  
Allergic diseases, such as asthma, eczema, and rhinitis, increased dramatically in the 
western world during the last third of the 20th century, and today, about 30% of the Swedish 
population has one or more allergic symptoms. The reasons for this dramatic increase are 
unclear, and several culprits have been hypothesized, including less exposure to bacterias 
(the hygiene hypothesis), changes in the microbiota of the guts, and stress. 
Problems with stress are common in today’s society, with stress related problems being 
the most common reasons for sick-leave in Sweden 2010. Although the commonly held 
belief that stress always leads to negative consequences is held as incorrect within the 
scientific community, it is clear that stress changes the set-points and alters the conditions 
for the functioning of bodily systems, including the immune system. Sleep, on the other 
hand, is important for restoring the balance of homeostatic and allostatic systems in the 
body. Disturbed sleep equals impaired recuperation, and can also be seen as a stressor in 
and of itself.  
Many allergic patients make a connection between stressful situations and allergic 
symptom exacerbations. In addition, allergic individuals often experience fatigue and 
disturbed sleep, especially when exposed to allergen. Whether the fatigue is a consequence 
of disturbed sleep, or if it is related to for instance alterations in the immune system is not 
clear.  
Both stress and impaired sleep have been shown to cause shifts in physiological  
systems that would be of clear relevance for allergies, but the relations between stress, 
sleep, and allergy have not been extensively studied. Opinions about stress and its effects 
are abundant, but firm knowledge is still lacking about many (if not most) aspects of the 
stress process, not least in allergic individuals. In relation, the function of sleep in allergic 
disease and its potential role in development of allergic diseases is very poorly understood. 
Moreover, although sleep in allergic individuals is often impaired, no trials have been 
conducted that test the possibility to treat insomnia in allergic individuals. 
Therefore, this thesis is concerned with the relations between stress, sleep, and allergy, 
and in increasing the understanding for links between stress and allergy, and sleep and 
allergy.  
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2 BACKGROUND 
 
2.1 THEORETICAL FRAMEWORK  
 
2.1.1 Behavioral Medicine 
I first started working as a clinical psychologist in the area of behavioral medicine. 
Behavioral medicine to me means working with individuals with medical problems from a 
psychological perspective, and other behavioral or social sciences can also be involved. My 
first job was in rehabilitation of patients with coronary artery disease (CAD), and 
individuals at risk for developing CAD or other stress related problems. That is where I got 
interested in stress.  
An early definition of the field of behavioral medicine is “… the field concerned with 
the development of behavioral-science knowledge and techniques relevant to the 
understanding of physical health and illness and the application of this knowledge and these 
techniques to diagnosis, prevention, treatment and rehabilitation. Psychosis, neurosis and 
substance abuse are included only insofar as they contribute to physical disorders as an end 
point.” [1]. Behavioral medicine is concerned with a big picture; it is not enough to just look 
at the sick part – for instance the heart – of the person, but in order to understand and help 
as best as we can, we need to take into account the person’s behaviors and cognitions, the 
situation the person is in, perhaps the whole society and culture they live in. This project 
includes a study evaluating a psychological treatment for insomnia. Although treatment of 
insomnia is not the main focus of this project, this is a typical behavioral medicine 
approach. In many traditional medical problems, there are aspects that can be understood 
and treated with knowledge from behavioral sciences.  
This PhD thesis is a work within the behavioral medicine area. It is concerned with 
developing knowledge in the psychological area, contributing to the understanding of a 
medical problem; allergy.  
 
2.1.2 Psychoneuroimmunology 
Although the assumptions that events outside the body (e.g. stressors) can affect events 
inside it (e.g. heart beat, vigilance), and that different processes within the body can affect 
each other (e.g. psychological and immunological processes) can be seen as part of a 
behavioral medicine view of the world, these relations are also part of a more basic research 
area, namely psychoneuroimmunology (PNI). PNI has been described as “the study of 
behaviorally associated immunological changes and immunologically associated behavioral 
changes that result from reciprocal interactions among the nervous, endocrine, and immune 
systems” [2]. Rather than looking at changes in one system at a time, PNI research focuses 
on these interactions among the body’s systems, and relates these interactions to a person’s 
behaviors. In later sections, different aspects of these relations will be described more 
thoroughly. Here I just want to emphasize that such interactions are well established and of 
utmost importance for what is commonly referred to as stress. This project investigates 
relations between event in the environment, event inside the body, and overt behavior. 
This PhD thesis is thus also a work within the PNI-area; it is concerned with the 
relation between behaviors and the systems within the body.  
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2.2 STRESS 
Since stress in the everyday use of the word has a very negative ring to it, I here want to 
make clear that stress is not all bad. On the contrary, one main effect of the stress response 
is to free energy and re-distribute it to increase breathing frequency, heart rate, blood-flow 
etc. This is obviously advantageous in certain extreme situations, for instance each and 
every time one needs to run away from roaring lions. In addition certain cognitive functions 
are enhanced on a short term [3, 4], which make us able to focus exclusively on the lion 
until we are safe. After having escaped, they help us remember important aspects of the 
situation, such as where the lions were hiding.  
But the so called stress systems (or allostatic systems, see below) in the body are not 
only responsible for preparing the body in situations of acute danger, the same systems are 
also involved in everyday functions, such as adjusting the blood pressure upon anticipation 
of changing position from horizontal to up right, and for keeping us awake and alert during 
the day. In these functions, activation of the stress systems is far from bad. 
Thus, well-adjusted activations of the stress systems are adaptive and particularly well 
suited for short-term situations where high demands are placed on the organism. However, 
if the stress response is activated for too long, or too often it increases the risk for a number 
of problems [3], where some pertain to the function of the individual, and some to the direct 
health of the individual. This will be discussed in more detail below. 
The nature – duration and course – of stressors have implications for the effects on the 
body [5]. In their meta-analysis of stress effects on human immune function, Segerstrom & 
Miller [5] adopt a taxonomy for characterization of stressors, (developed by Elliot and 
Eisdorfer in 1982), which includes five categories. Laboratory challenges, such as public 
speaking, and other similarly stressful, but short and passing, events are denoted acute time-
limited stressors. Academic examinations or other events when a person confronts a real-
life short-term challenge, are called brief naturalistic stressors. In stressful event sequences, 
one major event, such as the loss of a spouse or a major natural disaster, gives rise to 
subsequent related challenges, the end of which may be difficult to foresee, but is expected. 
Challenges that are not expected to end, or where it is highly uncertain when they will end, 
such as traumatic injury, being a refugee, or caring for a chronically ill child, are called 
chronic stressors. Such stressors also force changes to a person’s identity or social roles. 
Finally, distant stressors, examples of which are childhood sexual abuse or war, have 
occurred in the distant past, but continue to have an impact on stress system and immune 
system function long after the event took place. Different effects of these different types of 
stressors will be discussed below. 
 
2.2.1 Definitions of stress 
Three broad traditions in stress research each have their own focus. The environmental 
tradition focuses on environmental events that are (“objectively”) associated with 
substantial adaptive demands and their relation to disease; the psychological tradition has its 
focus on the individual’s subjective evaluation of the demands and resources at hand and 
the relation between the subjective experience and disease; and the biological tradition is 
most interested in changes in different biological systems in response to demanding 
conditions [6].  
The three traditions have their own definitions of stress, and since I am a psychologist, I 
first looked into definitions of stress from the psychological tradition. Psychological 
definitions of stress have often focused on consciously perceived discomfort, and the 
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process from appraisal to discomfort (see below), whereas the relation between any event 
and the appraisal of the event is oftentimes ignored [7], as are any (biological) mechanisms 
leading to disease. For instance Richard Lazarus, one of last century’s most influential 
psychological stress researchers, states that: “Stress arises when individuals perceive that 
they cannot adequately cope with the demands being made on them or with threats to their 
well-being.”[8] Or as he later put it, simply: “Stress results from an imbalance between 
demands and resources” [9]. Others have had even more focus on the psychological aspects, 
and as I understand it, exclude any event that is not consciously appraised: “Stress, it is 
argued, can only be sensibly defined as a perceptual phenomenon arising from a comparison 
between the demand on the person and his or her ability to cope. An imbalance in this 
mechanism, when coping is important, gives rise to the experience of stress, and to the 
stress response.” [10] Interestingly, the same author later explains that stress cannot be 
measured biologically, only correlates of stress can [11]; by this definition, stress IS the 
experience. 
Although the Lazarus definition definitely has some merit, I cannot easily accept a 
definition of stress that appears to preclude non-consciously evaluated events, and my 
interest in PNI put me into contact with the more biologically oriented definitions. For 
instance, George Chrousos states that stress is “a condition threatening homeostasis, which 
can be restored by a complex repertoire of physiological and behavioral responses of the 
organism” [12]. Firdaus Dhabhar claims that stress is “a constellation of events, consisting 
of a stimulus (stressor) that precipitates a reaction in the brain (stress perception), which 
activates physiologic fight-or-flight systems in the body (stress response)” [13]. In both 
these definitions the translation from external to internal events is implicitly recognized, but 
the emphasis is not on this process.  
I prefer Dhabhar’s definition because it implies a process, and explicitly includes 
perception and evaluation of events (happening in the brain), but this perception and 
evaluation need not necessarily be consciously experienced. From a PNI-perspective, it is 
hard not to include also non-consciously perceived events such as immune challenges in the 
term stressor, since they threaten the stability of the internal milieu - that is, “a stimulus to 
the organism that activates the stress system to help reattain homeostasis” [14]. This also 
rhymes well with theories of emotion; for instance in a resent symposium on feelings and 
emotions, several leading emotion theorists such as Arne Öhman and Antonio Damasio [15, 
16] underline the ability of non-consciously appraised stimuli to elicit emotional responses, 
and emotional responses are defined as “bioregulatory reactions that aim at promoting […] 
the sort of physiological states that secure [...] survival […]” [16].  
This is an important aspect, and the Dhabhar definition unfortunately has nothing to say 
about emotional responses. In addition, it does not explicitly mention reactions to stress 
other than the fight-or-flight response (which can to a large extent be seen as equivalent to 
the fear response [15, 17]).  
Despite these shortcomings (which may be account for in models of stress (see below) 
rather than plain definitions), it makes use of some of the premises of this thesis, which are 
that stressors are events (whether in the environment, in the body or in the mind) which 
cause stress – or rather a stress response. A stress response involves changes that can be 
observed psychologically as well as biologically. Psychological changes involve health 
behaviors, fight-flight-freeze-reactions, and increased vigilance with anxiety and feelings of 
worry. Biological changes involve activation of stress hormones, (autonomic) neural 
functions and function of the immune system.  
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These are then some basic premises, but how do these aspects relate to one another? 
That, of course, is not entirely clear yet, but several models and theories of stress have been 
developed.    
 
2.2.2 Theories and models of stress 
2.2.2.1 Earlier models 
The question of how an event in the environment (a stressor) “enters” the body has been 
discussed over the years. In 1950, a book entitled “Life Stress and Bodily Disease” [18] 
summarized a symposium concerning man’s reaction to stress. Evidence was put forward 
“that stressful life events, by evoking psychophysiological reactions, played an important 
causative role in the natural history of many diseases” [in 19]. The idea was quite crude; an 
event in the environment causes psychophysiological reactions in the body. For some time, 
the debate was on the nature of the event; Holmes & Rahe [19] and others were mostly 
interested in larger life events, such as death of a spouse, marriage or change in economic 
situation, a view that was questioned by for instance Kanner [20], who were more interested 
in the effect of daily hassles. Kanner and others [21] theorized that disrupted daily routines 
and minor daily annoyances could also be mediating the effects of larger life events. In 
1976, Richard Lazarus noted that something was lacking – individuals reacted differently in 
similar situations – and entered psychological processes into the equation [22]. The Lazarus 
& Folkman theory of stress [9] emphasizes appraisal of a situation to be central to whether a 
stress-response will be evoked or not; not the situation in and of itself. Coping was a 
concept introduced to cover what we do to handle stress. Over the years in research on 
stress and appraisal, Lazarus came to appreciate emotion as central to stress, and in 1999 he 
concluded: “The three concepts, stress, emotion, and coping, belong together and form a 
conceptual unit, with emotion being the superordinate concept because it includes stress and 
coping” [23]. And, as Margaret Kemeny recently noted in a chapter on emotions and the 
immune system [24]: “Today, many stress and coping theorists consider affective states to 
be the final link in the chain from the environmental perturbation to the biological response.  
In other words, coping processes and social support, for example, are posited to act on 
physiology by modifying the affective response to a given context.” Kemeny distinguishes 
between different types of affective experiences, and defines emotions as short, intensely 
felt affective states that are associated with distinctive facial expressions and behavioral 
dispositions (much similar to Damasio’s definition above); moods as longer-term affective 
states that do not necessarily have a specific trigger, may involve a blend of different 
affective responses, and are often accompanied by persistent and distinctive cognitions. This 
bears similarities to Damasio’s definition of feelings; “Feelings depend on the perception of 
a changed body state alongside the perception of a certain style of mental processing of 
thoughts with themes consonant with the emotion” [16]. Kemeny further denotes affective 
traits as a dispositional tendency to experience specific emotions and moods across 
situations and over time; and finally affective disorders as pathological forms of affective 
experience that interfere with daily life, such as major depressive disorder or generalized 
anxiety disorder [24].  
Early on, and partly independent of these psychological models of stress, the more 
physiologically oriented models developed. An early model was Walter Cannon’s fight-or-
flight [25]. Cannon also used the term “homeostasis” – stability – meaning the relatively 
constant internal milieu that was upheld, despite external changes. Later, Hans Selye 
described “the general adaptation syndrome” [26]. In the 1940’s he observed that animals 
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exposed to different stressors showed similar patterns of physiological damage; thickening 
of the adrenal cortex, shrinkage of thymus and lymph tissue, and gastric ulcer. He found 
that this response could be divided into three phases: 1) the alarm phase where the organism 
attempts to adjust to meet the demands by secreting corticosteroids, 2) the resistance phase 
where the organism adapts to the stressor and symptoms disappear but with remaining 
elevation of corticosteroids, and 3) if the stressor is prolonged, the exhaustion phase where 
the organism is no longer able to secrete sufficient amounts of corticosteroids and thus 
looses its ability to adapt to the stressor [26].  
 
2.2.2.2 Stress as a process 
As disparate as these approaches may seem, they do share an interest in the process by 
which events in the environment – and not pathogens directly – result in increases risk for 
disease. Cohen, Kessler & Gordon [6] described this as ”an interest in a process in which 
environmental demands tax or exceed the adaptive capacity of an organism, resulting in 
psychological and biological changes that may place persons at risk for disease”. They 
attempted to integrate the different perspectives into one theoretical model. Basically, 
Cohen et al. see the three traditions (environmental, psychological and biological) as 
focusing on different stages of the stress process “through which environmental demands 
are translated into psychological and biological changes that place people at risk for 
disease” [6], and each of the stages, is of course of interest for the understanding of this 
process. So while the earlier models mentioned may be seen as focusing on separate stages 
of the process, the “unifying model” of Cohen et al. can be seen as a model of the process as 
a whole. 
A newer and potentially interesting theory of stress as a process is the “The Cognitive 
Activation Theory of Stress (CATS)” by Ursin & Eriksen [27]. It differs from the other 
models mentioned in that it is a more formalized theory, and in that it certainly aims at 
including every step of the stress process. One of the main differences is in the appraisal 
part of the process. Rather than seeing appraisal of the situation as central to whether a 
stress response occurs, as the Lazarus appraisal model states, these authors underline that 
“the stress responses are normal activation responses leading to an increase in arousal, and 
corresponding changes in behavior as well as in most or all parts of the body”.  
 
2.2.3 The allostasis model 
For my work in this project, however, the most influential model has been the allostasis 
model [28]. The allostasis model came out of the observation from many researchers that 
stress is not always bad, and was developed in an effort to account for the findings that 
stress sometimes seems to improve immune functioning – and health. The model is based 
on the definition of stress involving challenge to homeostasis, and is also a model viewing 
stress as a process. It states that challenge to homeostasis causes so called allostatic 
responses [29] aimed at protecting the organism from deviations from homeostatic set-
points. For example, in order to keep constant oxygen tension in the brain (homoeostasis), 
blood pressure needs to be variable (allostasis), depending on for instance if we are lying 
down, anticipate to rise, or start running [3]. Bruce McEwen explains that: “The 
maintenance of homeostasis is an active process that requires the output of mediators such 
as those of the autonomic nervous system, and the neuroendocrine and immune systems. 
This process is called ‘allostasis’, or ‘maintaining homeostasis through change’” [30]. Many 
(if not all) systems in the body are included in the allostasis network, and the mediators of 
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allostasis need to be tightly regulated. The regulation of the allostatic mediators is reciprocal 
– i.e. the mediators regulate each other – and non-linear, within the network. If the 
regulation is disturbed so that too much or too little of a mediator is at work, the entire 
network may be perturbated, with harmful consequences [30]. Potentially damaging effects 
of allostasis are denoted allostatic (over)load, which thus connects exposure to stressors 
with health outcomes (e.g. expression of disease) [28]. According to the model, there are 
four conditions that, over time, lead to allostatic load; “1) Repeated hits, a normal response 
to novel stressors, repeated over time 2) a lack of adaptation 3) prolonged response due to 
delayed shut down, or 4) inadequate response that leads to compensatory hyperactivity of 
other mediators, e.g. inadequate secretion of glucocorticoid, resulting in increased levels of 
cytokines that are normally counter-regulated by glucocorticoids.”  
In this model, behaviors of the individual are also considered important for protection 
or damage. Behavior and cognition are seen as important for determining what is stressful, 
and based on individual differences, including (but not limited to) both experience and 
genetic variations, people differ in their appraisal of what is stressful, and in the 
physiological response mounted in response to the potential threat. Individual differences 
also include the condition of the body itself; a physically fit person will be more resilient to 
stress and the response to challenge will have less adverse effects. Finally, responses to 
challenge can take the form of altering behaviors, for instance increasing smoking or 
drinking, which have perceived soothing effects in the short run, but add to the 
physiological allostatic load in the longer run. 
Although the function of affective states is implied and sometimes talked about 
explicitly, their exact place is somewhat unclear within the allostasis model. My preliminary 
understanding is that they could be conceptualized as differing according to the stage in the 
process. Perception and interpretation is involved in the encounter with the stimulus, and in 
the allostasis model, threat, helplessness and vigilance are included in stress perception [28]. 
Stress perception is posited to initiate behavioral and physiological responses. An emotion, 
as categorized by Kemeny [24] can thus be seen as part of the response itself [16]. Affective 
disorders are clearly stated as parts or signs of allostatic overload [31]. However, exactly 
where (negative) moods, or feelings come in is a bit obscure, but they could be seen as part 
of an ongoing stress response, since for instance worry and anxiety are seen as resulting in 
allostatic load [32]. If a further distinction needs to be made, (negative) affective traits could 
tentatively be seen as signs of allostatic load, since feelings of fatigue, lack of energy, 
irritability and hostility has been referred to as “chronic stress” [28].  
In sum, in this thesis stress is seen as a process, rather than a state or stage. The process 
starts with 1) an event – the stressor – 2) being (sometimes non-consciously) perceived and 
evaluated by the organism – stress perception – and possibly only if evaluated negatively 3) 
eliciting a stress-response or allostasis aimed at protecting the organism, but which may 
under certain circumstances 4) heavily charge the systems – allostatic load – and 5) 
ultimately compromise mental and physical health – allostatic overload. The line between 
allostasis and allostatic load is not entirely clear, but one option is to view allostasis as a 
process, while allostatic load is a state, albeit a changing state. What is clear is that 
“Allostatic load refers to the cumulative cost to the body of allostasis” [33], so while 
allostasis may refer to short term alterations, allostatic load has to do with more long term or 
chronic alterations.  
According to the model, not only physiological changes are included in the stress 
response and allostatic load, but also behavioral and emotional changes, which may then 
feed into the process and either perpetuate or help terminate the stress response. Whether a 
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response has been effectively mounted and appropriately terminated also affects the ability 
to respond to subsequent stressors. However, exactly how stress responses are altered under 
the influence of allostatic load reminds to be clarified. Also the questions of how the 
evaluation happens, and what aspects of the event are being evaluated, are still under 
debate, although some kind of threat-appraisal is often understood. Likewise, the exact 
biological pathways leading to disease and moderating circumstances are only to a little 
extent understood.  
 
2.2.4 The biology of stress  
The entire central nervous system (CNS) is directly or indirectly involved in a stress 
response; the brain is initially responsible for perception of events, and for the interpretation 
and evaluation of the importance of events, and it is the brain which then initiates the 
appropriate (physiological as well as emotional) responses to the particular stimulus. How 
does the brain then convey its wishes to the rest of the body? There are several ways, of 
course, as always when something important is going on. 
 
2.2.4.1 Basic neuroendocrine signaling 
The nervous and the endocrine systems are intimately connected. The main connections 
from the nervous system to the endocrine systems are from the cortex to other areas of the 
brain, including the hippocampus, the hypothalamus, different areas in the brain stem, and 
the amygdala which seems to have a central role in the stress response. Neurons in the 
amygdala release corticotrophin releasing hormone (CRH) which has two major effects: 
1) The activation of the brain stem, which stimulates the sympathetic nervous system 
(SNS). The SNS then has two major pathways; a) nerve cells that reach target organs 
throughout the body, where the neurotransmitter norepinephrine (NE) is released, 
stimulating the organs directly, and b) via the adrenal medulla where the SNS nerve cells 
stimulate secretory cells to secrete a mixture of epinephrine (E, about 75%) and NE (about 
25%). E and NE may be secreted in slightly different proportions depending on the 
stimulus, but they may also have differing effects depending on which adrenergic receptor 
is stimulated (so called alpha or beta adrenergic receptors). However, activation of the SNS 
generally results in changes that characterize the fight-or-flight response such as increased 
heart rate and blood pressure, elevated breathing rate, increased blood flow to muscles, 
released energy stores into the blood, etcetera. This is the sympathetic adrenal medullary 
(SAM)-system, the maximum physiological effect of which occurs a few minutes after 
stressor onset 
The activity in the SNS is regulated and complemented by activity in the 
parasympathetic nervous system (PNS). I will not go into details about the PNS, but only 
mention the vagus nerve, or tenth cranial nerve, which is an important part of the PNS. The 
vagus innervates many tissues, including the heart and lungs where activity of the vagus 
lowers heart beat and breathing frequency – i.e. opposite actions compared to the SNS. 
2) The amygdala also activates the hormone producing cells of the paraventricular 
nuclei of the hypothalamus. The nerve terminals of these neurosecretory neurons also 
release peptides, such as CRH. These peptides are in turn important for releasing 
adrenocorticotropic hormone (ACTH) from the anterior pituitary gland, which in turn 
increase the production and release of glucocorticoids (GCs; e.g. cortisol in humans) from 
the adrenal cortex. This is the hypothalamic pituitary adrenal (HPA)-axis, from which the 
physiological effect occurs about one hour after stressor onset.  
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Cortisol crosses the cell membrane and binds to receptors in the cytoplasm, from which 
the receptor complex enters the cell nucleus and activates or represses different genes [34]. 
As part of a stress response, cortisol has several different roles. Background levels of 
cortisol permit the actions of other stress-related systems [35], for instance in the early 
stages of the stress response when GCs augment the actions of catecholamines (CAs). Also, 
while CAs act quickly, for instance to elevate blood glucose levels, cortisol acts mores 
slowly, in this case maintaining the high levels of glucose, partly by increasing insulin 
resistance [34]. 
In the early phase of a stress response (acute stress), CRH and NE stimulate the 
secretion of each other, through reciprocal neural connections between the above mentioned 
neurons. 
To turn off the stress response, there are “autoregulatory ultrashort negative feed back 
loops” in both the hypothalamic CRH and the brain stem catecholaminergic neurons, as 
well as several central regulatory pathways, for instance via the hippocampus and frontal 
cortex, the hypothalamus, and the pituitary gland. Importantly, GCs – the final effectors of 
the HPA-axis – are central not only for regulating basal HPA-axis activity but also for 
terminating the stress response [12].  
Both the HPA-axis and the SAM-system have allostatic effects in the body; helping to 
maintain homeostasis through the initiation of physiological change. Increases in GCs and E 
as well as NE are part of the healthy acute stress response, helping individuals handle acute 
stressors effectively [3]. As these stress hormones provide feedback to the brain, they also 
influence neural structures that control emotion and cognition [17], which is then how stress 
affects affect.  
Changes in these systems can also be seen in chronically stressed individuals, but long-
term alterations are generally considered negative [3]. One example of negative alterations 
is the attenuated cortisol awakening response seen, for instance, in patients suffering from 
depression [36]. Such alterations include a decreased capacity to initiate a healthy increase 
in for instance cortisol following acute stressors, thereby hampering the ability of the 
organism to mount an adequate response in other systems. 
 
2.2.4.2 The immune system 
The immune system’s main function is to protect the host from infection. There are different 
types of immune responses that work in concert to produce an optimal defense for the host. 
A distinction is made between innate and adaptive immune responses, where the innate 
response is fast and non-specific, whereas the adaptive response is somewhat slower, but 
has a type of memory enabling the cells to recognize specific antigens more quickly upon 
subsequent exposure. Within adaptive immunity a further distinction is made between the 
humoral and cell-mediated responses. A humoral response is mediated by antibodies and is 
directed to protecting against extra cellular pathogens and their toxic products. A cell-
mediated response on the other hand is the function of T-lymphocytes, and is needed to 
control intracellular pathogens, and to activate B-cell responses to most antigens [37].  
Cells of the immune system communicate with each other using so called cytokines 
which are crucial for mediating responses and for maintaining homeostasis within the 
immune system. Cytokines can signal back to the cell that secreted them, to nearby cells  
and to distant cells in the body. Cytokines activate immune cells for different purposes, and 
many cytokines have overlapping effects. Cells of the different branches of the immune 
system secrete different cytokines. For instance, cells of the innate immune system release 
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pro-inflammatory cytokines such as interleukin (IL)-1, IL-6 and tumor necrosis factor 
(TNF)-α, the effects of which are counter-acted by anti-inflammatory cytokines, such as IL-
4, IL-10 and IL-1ra. Within the adaptive branch cellular immunity is promoted by T-helper 
(Th) 1 cells, which secrete cytokines such as interferon (IFN)-γ , IL-2 and TNF-α. Humoral 
immunity is promoted by Th2 cells which secrete for instance  IL-4, IL-5, IL-10 and IL-13 
[38]. 
 
2.2.4.3 Basic neuroimmune signaling 
There are several ways for the central nervous system to signal to the immune system. 
Immune cells bear receptors for neurotransmitters, neuropeptides and hormones, and nerve 
endings reach the lymphoid organs (e.g. bone marrow and thymus) [39]. By these pathways, 
signals from the nervous system can be received by the immune system. This means that 
when the CNS detects changes in the environment or within the body, signals can be sent to 
the immune system.  
In turn, the immune system can signal to the nervous system. Neurons both in the 
periphery and centrally, have receptors for cytokines [40].  
Although cytokines are too large to pass the blood brain barrier, they can signal to the 
central nervous system through other pathways. One way is via peripheral nerves such as 
the vagus nerve, where efferent activation of the vagus nerve leads to inhibition of pro-
inflammatory cytokines, the so-called “inflammatory reflex” [41]. Cytokines can also signal 
to the brain over the blood brain barrier by activating second messengers such as 
prostaglandin E2, or simply by passing into the brain via circumventricular organs which 
lack the tight junctions of blood brain barrier [40, 42]. This way, changes in the immune 
system can be monitored by the brain, and the brain can send signals to alter the actions of 
the immune system. Such signaling is of relevance in inflammatory disease, since pro-
inflammatory cytokines (such as IL-1β and TNF-α) when signaling to the brain induces a so 
called sickness response [42] which includes fever, fatigue, malaise, and anorexia [43, 44]. 
In addition, some of those cytokines also promote sleep (see below), and alter cognitive 
functions.  
 
2.2.4.4 Stress induced immune changes 
Stress has been shown to induce changes in the immune system. However, depending on 
the nature of the stressor – acute time limited, brief naturalistic, or chronic – different 
immune alterations have been seen [5]. For instance, acute time limited stressors (e.g. public 
speaking and mental arithmetic, lasting between 5 and 100 minutes) have been shown to 
cause marked increases in the number of natural killer cells and large granular lymphocytes 
in peripheral blood [5], whereas chronic stressors (including dementia caregiving, and living 
with a handicap), like other nonacute stressors, show little effects on numbers of immune 
cells. Chronic stressors, however, show suppressing effects on almost all functional 
measures of the immune system [5]. 
These results concur with the findings of Dhabhar & McEwen [45] that ”acute stress 
enhances while chronic stress suppresses immune function”. Dhabhar & McEwen propose 
biphasic changes in blood leukocyte numbers, where the first surge of stress hormones – 
CAs – cause the body’s ”soldiers” (leukocytes) to exit their ”barracks” (e.g. spleen, lung, 
and other organs) and enter the ”boulevards” (blood vessels and lymphatics). The second 
part is when the HPA-axis is activated, and the release of GCs induce leukocytes to exit the 
blood and take position at potential ”battle stations” (skin, mucosal lining of gastro-
   11 
intestinal tract, etc.). This would be a preparation for potential immune challenges imposed 
by the actions of the stressor.  
It has also been shown that stress increases the production of pro-inflammatory 
mediators, such as the cytokines IL-1, IL-6, and TNF-α (for a review see [46]).  
Dhabhar & McEwen suggest a stress spectrum, where acute stress helps the individual 
cope effectively with environmental challenges, through allostatic processes mentioned 
above, whereas chronic stress is (generally) not seen as beneficial, ultimately resulting in 
allostatic load and health complications. These effects on health are at least partly due to the 
effects of long term stress on the functioning of the immune system described above. 
 
2.2.5 Measuring stress 
In order to study something, the “something” often needs to be measured. Measuring stress, 
however, is not entirely straight forward. From my point of view, The Stress Measure, 
which will explain everything about stress, probably does not exist. Instead, depending on 
one’s working model and the context of the research question, measurements will have to 
vary. For instance, if interest is in the relation between how appraisal relates to activity in 
the stress-systems, then appropriate measurements of these aspects are needed. Some stress 
researchers find that the differences in focus and approaches between disciplines should be 
maintained [47]. However, if “stress” is viewed as a process, and the overall aim is to 
understand all aspects of this process more fully, then measures can be made at any stage, 
some of the stages, or even all of them [6, 27]. 
An additional aspect is if the stress being measured is acute or chronic, since acute and 
chronic stressors differ in hormonal output, and also in the effects on the immune system [5, 
13]. It is therefore important to define the stressors measured, for instance according to the 
taxonomy proposed above. 
Few questionnaires have been developed which specifically examine the affective 
responses to stressors. In this project, I have used several different measures, including 
single item measures, such as a Visual Analogue Scale (VAS) for measuring stress 
experience, and a nine-step Likert-type scale to measure tension, both of which I 
conceptualize as measuring acute stress, or stress perception. I have also used measures of 
anxiety and depression, and psychological distress as part of the stress response – or 
allostatic load. 
Behavioral responses to stress are sometimes conceptualized as coping based on the 
Lazarus & Folkman model, in which case the Ways of Coping Questionnaire (WCQ, 
Folkman & Lazarus 1980) is commonly used. When not conceptualized this way, as in this 
thesis, different behaviors may be studied individually. I have focused on stress behaviors 
(i.e. type A behavior pattern) and sleep, since increases in stress behaviors and impairment 
in sleep can be expected to perpetuate allostasis and thereby contribute to allostatic load.  
Common ways of measuring biological aspects of the stress response are by measuring 
cortisol or CAs (see above), although several biological systems are involved and affect the 
activity of one another. Although it is not reasonable to think that one measure of one 
specific hormone would be a sufficient and objective measure of whether we are stressed or 
not, measurement of cortisol was included in study I. 
Since the disease of interest in this project is allergy, immune-parameters relevant to 
allergy were measured. This included the Th1/Th2 cytokine balance, and numbers of cells 
of types involved in the allergic reaction. 
In the methods section below I describe the measures used in this project. 
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2.3 SLEEP 
Sleep can be behaviorally defined as “a reversible behavioral state of perceptual 
disengagement from and unresponsiveness to the environment” [48].  
Sleep is essential, and provides us with rest and recovery from the day’s “wear and 
tear”, and is often seen as The Restoration – the most powerful way to balance the 
(negative) effects of activity. However, “wear and tear”, or at least “normal use” is needed 
to induce sleep. Sleep and wakefulness is an example of the homeostatic or allostatic 
processes the body is constantly balancing. McEwen states that “Sleep deprivation, even for 
the course of the active period of the day, increases the homeostatic drive to sleep, with 
resulting changes in pro-inflammatory cytokines and glycogen levels.” [30]. As most of us 
have experienced at some point, reduced or disrupted sleep results in increased sleepiness 
and reduced well-being the following day. 
Sleep consists of different “types” of sleep, called sleep stages. The most obvious 
distinction is between rapid eye movement (REM)-sleep and non-REM (NREM). As the 
name implies, REM-sleep is characterized by rapid eye movements, but (usually) under 
closed eyelids. NREM then, is simply sleep without rapid eye movements. NREM sleep is 
divided into three (traditionally four) different stages defined according to 
electroencephalogram (EEG), but differences are also seen behaviorally. For instance, stage 
1 is the “lighter” sleep, from which a person is easily aroused and may even feel he or she 
did not sleep at all, and stage 3, or slow wave sleep (SWS), is the deepest sleep stage, from 
which it is very difficult to wake a person. Stage 2, which is the intermediate stage, 
normally constitutes almost 50% of total sleep time. 
Although quite a lot is known about sleep, the overall question of why we sleep at all is 
a topic for discussion. However, without going into all the different hypotheses proposed, 
most sleep researchers agree that the need for sleep indicates an essential restorative 
function [49]. It is also clear that sleep is important for the functioning of many bodily 
systems, including the immune system [50], and the nervous system – for instance for 
cognitive functioning [51]. 
Sleep regulation has been described as a two-process model, closely regulated by 
circadian (“process C”) and homeostatic (“process S”) factors [52]. The circadian factor 
increases the likelihood of sleep onset at certain times of the day, and is more or less 
independent of sleep and waking, whereas the homeostatic factor increases the likelihood of 
sleep after a period of wakefulness, but decreases the likelihood of sleep after prior sleep. 
Process S increases with waking time and if previous sleep periods have been short or 
disturbed, and is reduced only during (slow wave) sleep. 
Circadian factors promote sleep around the so-called circadian trough (which occurs 
during the latter half of the habitual nocturnal sleep episode) and interferes with sleep 
during the peak. Through the interaction of circadian and homeostatic factors, sleep is 
consolidated to night-time, and wakefulness to day-time. Circadian factors are more 
important for REM-sleep timing, and homeostatic factors are more important for SWS 
timing. Interestingly, SWS is selectively increased in brain areas previously activated during 
wakefulness [53]. In addition, the immune system is an important homeostatic factor 
influencing sleep. Although the effects of central and peripheral cytokines may differ, the 
pro-inflammatory cytokines IL-1 and IFN-γ, that are also involved in the sickness response 
(see above), have been shown to be directly sleep inducing [54], and are likely involved in 
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the increase in SWS seen during infection [55]. Anti-inflammatory cytokines on the other 
hand inhibit sleep [50].  
 
2.3.1 Sleep and stress 
In relation to stress, sleep is vital, since allostatic load can occur when adequate recovery 
from stress responses does not take place [28]. Sleep is central for recovery; it is important 
for restoring homeostatic and allostatic systems in the body, including the immune system 
[50]. Sleep is also fundamental for the well-being of the individual and impaired sleep is 
tightly linked to psychological distress [e.g. 56]. McEwen [30] concludes that ”The long-
term consequences of sleep deprivation constitute a form of allostatic load—with 
consequences involving hypertension, reduced parasympathetic tone, increased pro-
inflammatory cytokines, increased oxidative stress, and increased evening cortisol and 
insulin.”.  
Several studies have shown a relation between self-rated stress and impaired sleep [57, 
58], and a majority of individuals with persistent sleep disturbances relate the onset to a 
stressful life event [59, 60]. In addition, stress is indicated in the maintenance of sleep 
disturbances [61], and activity in the stress systems is related to degree of objective sleep 
disturbance in individuals with chronic insomnia [62]. Thus, the development of insomnia, 
which is the most commonly occurring sleep disorder [63], is related to stress. In the general 
population, about one third suffers from one or more insomnia symptoms, and about 10% 
fulfill diagnostic criteria for insomnia [64].  
Diagnostic criteria (e.g. the diagnostic and statistical manual of mental disorders 
(DSM) [65] and the international classification of sleep disorders (ICSD) [66]) include that 
the individual reports either difficulty initiating sleep, difficulty maintaining sleep, waking 
up too early, or having sleep that is chronically non-restorative or poor in quality. They also 
commonly include some form of day-time consequences related to the nighttime sleep 
difficulty, for instance fatigue; impaired attention, concentration, or memory; mood 
disturbance/irritability; motivation/energy/initiative reduction; and concerns or worries 
about sleep.  
Stress thus seems to be important for both the development and maintenance of 
insomnia problems [61, 67], and the Cognitive Behavioral model for insomnia, includes 
stress – or arousal – as an important factor, especially at the earlier stages [68].  
Stress and sleep are thus intimately linked, and through their mutual connection with 
immune regulatory processes, they are of high relevance for inflammatory diseases such as 
allergies [69]. 
 
2.4 ALLERGY 
Allergy is a strong, “abnormal”, immune-reaction to harmless substances. Allergic 
individuals are predisposed to a number of clinically expressed disorders, so called atopic 
diseases, e.g. atopic rhinitis (AR), atopic asthma and atopic dermatitis (AD). Such diseases 
are costly to society and often represent lifelong consequences to the individual. During the 
last decades, there has been a substantial increase in the prevalence of atopic diseases, 
mostly in the richer parts of the world, such as the western part of Europe and the US. In 
Sweden, almost 40 % of the children in school age have or have had allergic problems [70], 
and other studies have found as many as 1 in 3 individuals to suffer from some form of 
allergic disorder [71].  
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Obviously, finding out why allergic conditions have increased, and how to best help 
those suffering from allergic diseases, is of great concern.  
My interest in allergy started when I realized that life-style factors influence the 
expression, and possibly even the development, of atopic disease. For instance, paternal 
smoking [72], dietary factors [73, 74], growing up in rural or urban areas [75, 76], and stress 
[77] have all been shown to influence atopy. From a behavioral medicine perspective, all of 
these aspects would be of interest, but the relation to stress (and sleep) is obviously the most 
interesting one to me. Before going in to this relation, some background information is 
needed. 
 
2.4.1 Immune function in allergy 
In allergy, reactions occur since the individual has previously become sensitized – started 
producing antibodies – to antigen such as food or pollen (then called allergens). Upon 
subsequent exposure to the same or a similar allergen, the adaptive immune response causes 
a production of antibodies [78], whereupon follows a number of additional events leading to 
the typical expressions of allergy (e.g. runny nose, or difficulties breathing). 
There are different kinds of allergic immune reactions, but the most common is the so-
called type I hypersensitivity resulting in diseases such as allergic rhinitis and asthma. 
Oftentimes, a so-called type IV hypersensitivity, or delayed type reaction, is also present 
especially in the chronic forms of asthma and rhinitis [78]. 
As mentioned above, these diseases are often referred to as atopic diseases, and atopy is 
defined immunologically as a genetic tendency to form immunoglobulin E (IgE)-antibodies 
towards common antigens in the surrounding environment [79]. In addition, a dominance of 
Th 2 cytokines over Th1 is by many considered a central feature [80]. Th1 cytokines 
include IL-2, IL-12, IFN-γ, and TNF-β. Th2 cytokines include IL-4, IL-5, IL-9, IL-10, IL-
13. [81], and IL-6.  
The immune response in allergy is also characterized by mast cell activation and 
degranulation. Mast cells have strong receptors for IgE-antibodies, and when the receptors 
of the mast cells bind to the antibodies, the cells become active and empty their granules. 
The granules of mast cells contain an array of inflammatory mediators, such as histamine 
(causing an immediate increase in local blood flow), different enzymes (causing tissue 
destruction) and the pro-inflammatory cytokine TNF-α (promoting influx of inflammatory 
leukocytes and lymphocytes into tissues). In addition, Th2 cytokines such as IL-4 and IL-13 
are released, which perpetuate the Th2 response (by for instance inducing IgE production, 
and so called isotype switching to IgE), and signal to other important cell types, such as 
eosinophils and basophils, B-cells and dendritic cells, which come to the site and add to the 
inflammatory cascade [78, 82].  
In addition to these well-established “allergic” immune processes, two other cell types 
need to be mentioned in the present context. The first is regulatory T-cells, whose role is 
usually one of moderating inflammation, and producing inhibitory cytokines to spare 
surrounding tissues from collateral damage [83]. However, regulatory T-cells in atopic 
individuals have been shown to be deficient in downregulating Th2 mediated inflammation 
[84]. Finally, natural killer (NK) cells that are usually involved in the defense against cancer 
cells, have been suggested to play a role in atopy and asthma, not least due to their capacity 
to secrete Th1 cytokines such as IFN-γ [85]. However, NK cells may also produce Th2 
cytokines, such as IL-5 and IL-13 [86], and in a model where NK cells promoted allergic 
disease, they produced high levels of the Th2 cytokine IL-5 [87]. 
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2.5 STRESS, SLEEP, AND ALLERGY 
2.5.1 Stress and immuno-endocrine parameters relevant to allergy 
Acute stress then, is associated with an increase in stress-system activity; arousal through 
the SNS (i.e. the SAM system) and HPA-axis (se above), and corresponding increases in 
CAs and GCs. GCs are generally anti-inflammatory [88], suppressing pro-inflammatory 
actions, and augmenting anti-inflammatory agents in the immune system.  
In their 1999 review, Elenkov & Chrousos conclude that both GCs and CAs promote a 
Th2-cytokine (allergy-related) profile. CAs suppress the production of Th1-cytokines such 
as IL-12 and IFN-γ, thereby promoting a Th2-profile, whereas GCs in addition to 
suppressing IL-12, also up-regulate the production of Th2-cytokines, e.g. IL-4, IL-10 and 
IL-13 [89]. Thus physiological levels of GCs may be immunomodulatory rather than solely 
immunosuppressive, causing a shift in cytokine production from a Th1 to a Th2-type 
pattern.  
Due to their anti-inflammatory properties, GCs represent standard care for persistent 
allergic diseases [78]. However, increased serum IgE-levels can be seen in allergic 
individuals treated with GCs [90, 91]. Recent studies have shown both pharmacological and 
physiological levels of GCs to increase production of IL-4 and suppress IFN-γ [81], and IL-
4 is a Th2-type cytokine which among other things induce IgE-production [78].  
In addition to the increased systemic levels of GCs seen during stress, CRH may be 
produced by sympathetic neurons and by immune cells locally in inflammatory sites, 
activating mast cell degranulation, and increasing allergic activity [92].  
Stress, then, alters the level of circulating stress hormones. In addition to these 
alterations, the sensitivity of target organs (e.g. neurons of the hippocampus, blood vessels, 
white blood cells) may differ between individuals [93], and both steroid levels and target 
cell sensitivity are important to determine the physiological net effect [94]. The feed-back in 
the HPA-axis is crucial to a well-balanced immunological response [95], and studies in both 
animals and humans indicate that pathological consequences of altered regulation in the 
stress systems are relevant in allergic disease [96-99]. 
Stress has several effects on the immune system important for allergy. Many studies 
have shown stress to cause a shift from Th1 to Th2 profile [e.g. 100], and this is also the 
conclusion of a recent review on the subject [101]. In the previously mentioned meta-
analysis by Segerstrom & Miller on effects of stress on the immune system, this shift is 
consistently seen in studies investigating the effects of “brief naturalistic stressors”, such as 
exam-stress [5]. 
In atopic individuals, both IgE-levels and eosinophil numbers in blood samples have 
been shown to increase in response to an acute time-limited stressor [102]. Stress has also 
been shown to increase eosinophilic airway inflammation to antigen challenge [103]. In the 
same line, a number of studies on stress- and allergy-relevant immune parameters have been 
performed by Hajime Kimata. He found that computer stress and frequently ringing mobile 
phones enhanced skin wheal and IgE-responses in patients with AD, whereas both emotions 
with tears, kissing, and laughter (watching a Charlie Chaplin movie) significantly reduced 
skin wheal and IgE responses to allergens in AD-patients [104-109].  
In sum, evidence is accumulating that a broad range of immune parameters important 
in allergy are affected by stress, in ways that would enhance an allergic response. 
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2.5.2 Stress and allergic symptoms 
Patients, both with asthma and AD, often report that stress and worry contribute to 
exacerbations in allergic symptoms [110, 111]. For instance, the stress associated with 
experiencing an earthquake was shown to exacerbate AD symptoms in over 35% of patients 
[112]. In the same line, high levels of stress have been shown to predict higher asthma 
morbidity in children [113]. Finally, acute stress against the back-drop of chronic stress has 
been shown to exacerbate asthma symptoms more and with a sooner onset, than acute stress 
with no chronic stress, or chronic stress only (which did not have an effect on the risk for 
asthma exacerbations) [114]. However, other studies have found no association between 
stress and allergic symptoms [115], or functional measures of allergic disease (e.g. lung 
function) [116]. 
From an opposite viewpoint, interventions aimed at reducing stress and anxiety, can 
improve symptom severity. Data suggest that anxiolytics may alleviate stress-associated 
itching in patients with AD [117], and a recent review on psychological interventions 
concludes that “psychological interventions had a significant ameliorating effect on eczema 
severity, itching intensity and scratching in atopic dermatitis patients” [118].  
In sum, there is evidence that allergic symptoms are affected by stress and that 
interventions aimed at reducing stress or anxiety may alleviate allergy symptom severity. 
However, there are also studies that have not found such a connection, pointing to a need to 
further clarify the specific circumstances associated with stress related allergic symptom 
exacerbations. 
 
2.5.3 Allergy as a stressor 
We have now seen that stress can affect a number of allergy relevant systems in the body. 
Based on the allostasis model, disease could also be viewed as a stressor, since disease is a 
threat to homeostasis requiring changes in the body’s systems. However, allergic disease 
has not been discussed in this context.  
Evidence of a connection in this direction can be seen for instance in a recent animal 
experiment, which showed that allergy sensitization and allergen challenge of animals 
induced anxiety-like behavior as well as a Th2-cytokine profile [119], suggesting anxiety to 
be an effect of the allergic disease.  
In human studies, such experiments obviously cannot be performed. Different 
approaches have therefore been used to look for differences between allergic and non-
allergic individuals, and different stages of the stress process have been investigated. If 
allergy in itself is a stressor, then perhaps the perception of acute stressors would be altered? 
This is not evident, since several studies have not shown a difference in perceived stress in 
relation to an experimental or quasi-experimental stressor between allergic and non-allergic 
participants [e.g. 102, 120].  
However, many studies have shown an association between allergy and psychological 
aspects of allostatic load – i.e. increased levels of distress [e.g. 117, 121, 122]. Recently, a 
meta-analysis of prospective studies found allergy to be strongly associated with future 
psychological distress (and also psychosocial factors to be predictive of future allergy) 
[123]. In line, clinical observations of increased risk of suicide among allergic patients, 
findings that suicide peaks in spring, and of Th2-cytokine expression in the orbito-frontal 
cortex of suicide victims has also led to a suggestion that allergic inflammation may 
increase the risk of suicide [124].  
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Allergic individuals have been shown to exhibit altered responses to stress in both the 
HPA and SAM systems [125], and alterations are seen already in infants with atopic 
disposition [126]. In children and adults (but not in infants), the HPA-response to stressors 
is blunted (see [88] for a review), especially when exposed to allergen [127]. This has 
consequences for the ability of the endocrine system to help control immune processes 
during inflammation. For instance, during an inflammation, pro-inflammatory cytokines, 
such as TNF-α, IL-1 and IL-6, are released. Pro-inflammatory cytokines stimulate the HPA-
system [95]. This normally increases the levels of GCs, which have an anti-inflammatory 
effect (see above). However, the decreased response in the HPA-system could result in an 
inability to shut of the inflammation, leading to an ongoing inflammatory process (e.g. 
chronic allergic condition). Buske-Kirschbaum et al. propose that “…because of defective 
HPA axis, immunoregulation under stressful conditions is ineffective in patients with atopic 
conditions, leading to aberrant immune responses and subsequent exacerbation of the 
disease” [128]. 
The SAM-system, on the other hand, seems to be over reactive in allergic individuals 
[125]. As mentioned above, CAs mediate a Th2-shift, both by suppressing Th1 and up-
regulating Th2 cytokine production [14], which could then also contribute to disease 
exacerbations. 
Like the HPA-system, the vagus nerve is stimulated by pro-inflammatory cytokines. 
This stimulation normally turns on an “inflammatory reflex”, i.e. activates the vagus’ 
cholinergic anti-inflammatory pathway [41, 129]. In allergy, the effects of vagus nerve 
stimulation has been researched for several decades (at least since the 1970’s [130]), 
although to my knowledge not in the context of altered anti-inflammatory function, but 
rather in terms of broncho-constriction and, for instance, mast cell activation [e.g. 131, 132]. 
However, one recent study that found a shift in autonomic balance toward parasympathetic 
predominance in patients suffering from atopic dermatitis, discusses the anti-inflammatory 
function as well [133]. 
Taken together, allergic inflammation may be seen as a stressor, adding to the allostatic 
load for individuals suffering from allergic diseases. 
 
2.5.4 Impaired sleep and allergy 
A considerable percentage of insomnia-sufferers present with co-morbid problems [134], 
and a considerable proportion of allergic patients have impaired sleep [135-140].  
Several recent findings suggest that disturbed sleep may be a link between stress and 
atopy. As noted above, sleep is a highly important restorative process influencing 
homeostatic and allostatic systems in the body, and with great importance for the function 
of the immune system; fatigue and increased sleep are part of the sickness response seen 
during inflammation [141]; and sleep is often impaired in allergic individuals (but as with 
stress it is difficult to establish the causal direction of this relationship). Everyday stress is 
related to disturbed sleep in healthy individuals [58], and sleep disturbances, even in the 
absence of atopy, is related to a shift in the cytokine balance toward a Th2-response [142]. 
In addition, it has been hypothesized that sleep loss might be responsible for some of the 
immune system changes that accompany stressors [143, 144]. For instance Hall et al. [143] 
found that effects of stress-related intrusive thoughts and avoidance behaviors on lower 
numbers of circulating NK cells were mediated by greater time spent awake during the first 
sleep cycle.  
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In line, it has been suggested that sleep disturbances can worsen the course of chronic 
inflammatory conditions, such as asthma and allergic rhinitis [69], and sleep deprivation has 
been shown to enhance allergic skin responses [145]. 
Some studies have shown improvements in sleep after treatment of the allergic disease 
[146, 147], but it has also been suggested that some patients treated to full remission in 
allergic symptoms still suffer from impaired sleep [148].  
Insomnia has well-known long term negative consequences, for instance in the 
increased risk for depression [149]. This could be due to long-term consequences of sleep 
deprivation which, as we have seen above, constitutes a form of allostatic load [30, 31]. One 
obvious possibility for diminishing the risk of allostatic overload could then be to try 
improving sleep in individuals with impaired sleep. Since sleep is consistently shown to be 
impaired in allergic individuals, it would make sense to find out if a treatment for insomnia 
could improve their sleep. Perhaps by improving sleep, allostatic load could be diminished, 
ultimately leading to less health problems?  
 
2.5.4.1 Psychological treatment of impaired sleep – CBT for insomnia 
Cognitive behavioral therapy (CBT) has been shown to be an effective treatment for 
insomnia [150, 151] and is considered treatment of choice [152]. The Standards of Practice 
Committee of the American Academy of Sleep Medicine therefore recommends CBT for 
the treatment of insomnia [153]. 
CBT for insomnia includes both behavioral [68, 154, 155] and cognitive techniques 
[156]. The most thoroughly evaluated of the techniques described in the literature are sleep 
restriction (sometimes referred to as sleep compression) and stimulus control, but today 
CBT for insomnia usually includes a number of techniques, all of which may have some 
merit. For an overview of CBT techniques used in insomnia treatment, see for instance 
[155]. 
Although earlier studies of insomnia treatment tended to only treat primary insomnia, 
recent findings suggest that it may be worthwhile to treat the sleep problem first or in 
parallel with the additional problem(s) [157-159]. CBT for insomnia has thus been shown to 
be effective also for individuals with co-morbid problems [160], but attempts to treat sleep 
problems in individuals with allergy have not been reported. 
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3 AIMS OF THE THESIS 
 
This thesis aimed at investigating stress and sleep in the context of allergy. The main focus 
was on the stress response in allergy; sleep in times of strain and its involvement in the 
development of allergy, and the possibility to treat co-morbid insomnia.  
 
The specific questioned asked were: 
 
- How are allergy-relevant immune-parameters affected by a brief naturalistic stressor – an 
exam? (Paper I) 
 
- How are psychological functioning (levels of anxiety, depression, and tension), sleep, and 
allergic symptoms affected by the same brief naturalistic stressor (exam)? (Paper II) 
 
- Do sleep problems in childhood contribute to the development of allergic disease in 
adolescence, and vice versa? (Paper III) 
 
- How do individuals with disturbed sleep (insomnia) and co-morbidities including allergy 
respond to a psychological treatment for insomnia? If sleep is improved, are there any 
effects on allergic symptoms? (Study IV) 
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4 PROJECT DESIGN 
In order to answer the research questions in the project and to gain experience from 
different methodologies during my doctoral education, I have used studies with different 
approaches. The first two papers are based on a study with a quasi-experimental design, 
where medical students with or without atopy were observed at two occasions, i.e. during an 
ordinary study period and during a stressful examination period (Paper I and II). The third 
paper is an epidemiological study with a prospective design, using parent report data from 
the Twin Study of Child and Adolescent Development (TCHAD) about twins born in 1985-
1986 (Paper III). Finally, the fourth paper is a randomized controlled trial of the efficacy of 
a CBT-based self-help treatment for insomnia with co-morbid problems, including allergy 
(Paper IV).  
 
4.1 PAPER I 
Methods: Forty-one undergraduate students, 22 with allergy of whom 16 had asthma, and 
19 healthy controls, were studied in a regular study period and in association with a large 
exam. Of the atopic participants, 14 were female and eight male, with a median age of 25 
years (range 21-31 years). Non-atopic participants had a median age of 24 years (range 21-
27 years), 10 were female and nine male. 
Material: Subjects completed questionnaires on stress and health behaviors, underwent 
lung function tests, bronchial methacholine challenge, measurements of exhaled nitric oxide 
and urine cortisol. Blood cells were phenotyped, and cytokines from mononuclear blood 
cells were analysed. 
Statistical analyses: Wilcoxon’s signed-rank test, or a paired t-test for normally 
distributed data, was used for within subject comparisons. Mann–Whitney U-test, or an 
unpaired t-test for normally distributed data, was used for comparisons between subjects. 
Levels of cytokines were logarithmically transformed to normalize distributions. A p-value 
of less than .05 was considered significant. Gender distribution between the atopy and the 
control group was tested by a X2 test. Statistical analyses were performed using GraphPad 
Prism version 4.00 for Windows (GraphPad Software, San Diego, CA, USA). 
 
4.2 PAPER II 
Methods: = paper I  
Materials: Students completed questionnaires on stress, anxiety, depression, tension, 
stress behaviors (type A-behavior pattern) and self-rated health (SRH), and during one week 
during each period they filled out daily diaries on sleep and allergic symptoms.  
Statistical analyses: Analyses of variance (ANOVAs) were used to test for main effects 
of group (atopic vs. non-atopic participants), condition (non-examination vs. examination 
period), and interactions, for all variables except allergic symptoms. Allergic symptom item 
scores were Z-transformed before being aggregated since different scales were used. 
Exploratory factor analyses were performed on allergic symptom variables to reaffirm the 
division of items into categories of asthma, eczema, and rhinitis. Some items were excluded 
during this process due to zero variability or because they did not fall into the categories. 
Finally, for allergic symptoms, t-tests were performed to compare low-stress and stress 
allergic symptoms scores within the atopy group. (Allergic symptom scores were not 
calculated for the non-atopic group.) Effect sizes are given as ηp2, which is interpreted as 
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explained variance in the sample. All analyses were made with SPSS 15.0 for Windows 
(SPSS. Rel 15.0. Chicago: SPSS Inc.; 2006), and the alpha level was set to .05. 
 
4.3 PAPER III 
Methods: This prospective epidemiological study was based on data from the TCHAD 
study. The target sample consisted of all the 1480 twin pairs born in Sweden between May 
1985 and December 1986 who were alive and lived in Sweden.  
Material: We used parent-report questionnaires of asthma, rhinitis, eczema and sleep 
problems at wave 1 (in 1994) and wave 2 (in 1999), from which 1101 (75%) and 1063 
(72%) of the parents responded, respectively. 
Statistical analyses: Logistic regression models were developed to investigate the effect 
of (1) sleep problems at age 8 on asthma, rhinitis and eczema at age 13; and (2) asthma, 
rhinitis and eczema at age 8 on sleep problems at age 13. Increasingly complex models from 
bi-variate analyses to multivariate analyses were fitted to account for the confounding 
influences of a) pre-existing associations between the two assessments (i.e. the correlation 
between allergy and sleep problems at age 8-9) and stability in the outcome measure – e.g., 
the correlation between allergy assessed at age 8-9 and 13-14 (Model 2) and b) well 
established covariates, including birth weight and socioeconomic status (Model 3). Odds 
ratios (OR) with 95% confidence intervals (CI) were estimated using generalized estimating 
equations models, which allow us to account for the dependent nature of the twin 
observations. All the statistical analyses were performed in the SAS 9.1.3 using the 
GENMOD procedure (SAS Institute, Inc., Cary, NC). 
 
4.4 PAPER IV 
Methods: This randomized controlled trial included 133 media recruited participants with 
insomnia (109 women). Participants had a mean age of 47.9 (standard deviation (SD) 13.9) 
years, a long history of sleep difficulties (11.8 (SD 12.0) years), and most (92.5%) had co-
morbid problems (e.g. allergy, pain, or depression) including a large proportion with 
allergies (57.9%). Participants were randomized into three groups; self-help treatment only 
(n=45), self-help treatment with telephone support (n=44), and wait-list control group 
(n=44), and underwent assessment at base-line, after six weeks and after five months (i.e. 
follow-up assessment). The two treatment groups underwent the self-help treatment for 
insomnia during the first six weeks after base-line assessments, during which time the 
treatment group with telephone support also received one 15 minute telephone call per week 
from a therapist. The self-help book was based on established cognitive behavioral methods 
for insomnia, including sleep restriction, stimulus control, and cognitive restructuring.  
Material: Participants were interviewed and completed on-line, self-report 
questionnaires on sleep, psychological distress, and perceived stress, as well as one week of 
daily diaries on sleep and allergic symptoms at each assessment. 
Statistical analyses: One way ANOVAs and X2 associations were used to compare 
groups on background variables. Outcome data was analyzed for interactions between group 
and time-point, with Multivariate Analyses of Variance (MANOVAs) for the measures of 
1) sleep timing, 2) subjective sleep variables, and 3) day-time functioning and psychological 
distress. If interactions were significant for the MANOVAs, 2-way ANOVAs were used as 
follow-up tests for each variable for two groups at two time-points at a time, and analyzed 
for interactions – i.e. if and how groups differed in their response. ηp2, interpreted as amount 
of explained variance in the sample, was included as an effect size measure for interactions. 
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Change-values within each group were calculated with 95% Confidence Intervals, and for 
within group effect sizes Cohen’s d was used. ANOVAs were also calculated with the 
different co-morbid problems (e.g. allergy) as between-subjects variable instead of 
treatment group, and Insomnia Severity score.  For all analyses of variance, Huynh-Feldt 
corrections were applied when sphericity could not be assumed based on Mauchly’s Test of 
Sphericity. Thirteen outliers were found in sleep diary data, and following the 
recommendations by Tabachnick & Fidell [161], score alteration was performed in order 
not to lose valuable data, but lessen the impact of outliers. Treatment response and 
remission rates were calculated; as suggested by Morin et al. [162], participants were 
considered treatment responders if their Insomnia Severity Index (ISI) score changed with 8 
points or more compared to pre-assessment, and as treatment remitters if their absolute ISI 
score was less than 8. Except correlations and ANOVAS analyzing effects of co-morbidity, 
all outcome analyses are computed for intent-to-treat data with last observation carried 
forward, based on 133 pre-assessment questionnaires and 132 pre-assessment sleep diaries 
(one lost due to poor data quality). Analyses were conducted using PASW statistics 17 and 
18 (SPSS Inc. Chicaco, Illinois). 
 
4.5 ASSESSMENTS 
4.5.1 Stress 
Stress can be measured at different stages of the stress process. In this thesis, two measure 
of stress appraisal, or perceived stress, have been used. However focus has been on the 
stress response and allostatic load. Stress response measures include emotional and 
behavioral aspects of stress, as well as measures of endocrine and immunological aspects.  
 
4.5.1.1 Stress perception  
Paper I: Current, or acute, stress level was measured with a one-item Stress - Visual 
Analogue Scale (VAS). Students were asked to rate their overall level of stress on the VAS, 
a straight horizontal line measuring 100 mm, with anchors placed at both poles from “no 
stress” to “worst possible stress”. Participants were given written instructions: “Rate the 
level of stress you’re experiencing at this moment. Mark with an X on the line.” Despite its 
simplicity, the reliability and validity of VAS ratings has been demonstrated [163]. 
 
In paper II, acute stress was measured with a question about tension, phrased: “How do you 
feel right now” and to be rated on a 9 step scale, anchored at 1: feel very relaxed and calm, 
5: neither [relaxed] nor [tense], and 9: feel very tense and pressed, on the verge of what I 
can handle.  
 
Paper IV: Stress appraisal was measured with The Perceived Stress Scale (PSS-10) which 
measures perceived stress in daily life [164, 165]. The PSS-10 has 10 items with response 
alternatives 0 (never) to 4 (very often). Total score ranges from 0-40, and higher scores 
reflect higher levels of perceived stress. 
 
   23 
4.5.1.2 Stress response  
Psychological Distress, Anxiety & Depression 
In study II, trait anxiety was measured with the State-Trait Anxiety Inventory (STAI-T; 
[166]. State anxiety was measured with the Hospital Anxiety and Depression Scale (HADS) 
[167], which also measures depression.  
 
Study IV: The Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM) 
evaluates general psychological distress [168]. This 34 item scale has response alternatives 
0 (often) to 4 (almost all the time), yielding a total score between 0 and 112, and higher 
scores reflect more psychological distress. 
 
Stress behaviors  
Study II: Stress behaviors (so called Type A behaviors) were measured with The Everyday 
Life Stress scale [169]; 20 statements referring to stress behaviors in everyday life 
situations, with four response alternatives (coded as 0–3): 0, almost never; 1, sometimes; 2, 
often; 3, almost always. Total score ranges from 0 to 60, and it is commonly said that above 
30 points indicates an elevated level of stress behaviors, and over 40 points a very high 
level. 
 
Immune changes 
Study I: Complete blood count with leukocyte differentials was performed. Cells were 
analyzed by flow cytometry using a FACS-Calibur flow cytometer (BD, San Jose, CA, 
USA). In flow cytometry, cells are incubated with different antibodies that attach to cells 
with the right surface antigen or antibody receptor. The different antibodies are coupled to a 
fluorescent dye. Cells with glowing antibodies then pass through a thin tube in the flow 
cytometer, where they are automatically counted. Flow cytometry can give number and/or 
proportions of different types of cells.  
 
Study I Cytokines: Enzyme-linked immunosorbent assay (ELISA) (OptEIATM Human 
sets, Pharmingen, BD Biosciences, San Jose, CA, USA) was used to determine levels of IL-
2, IFN-g, IL-4 and IL-5 in supernatants from peripheral blood mononuclear cells. As with 
flow cytometry, ELISAs also use antibodies, but to detect proteins rather than cells. After 
several steps of preparation, antibodies and enzymes attach to the sought after protein, a 
substance is added that the enzyme can convert to a detectable signal, often a fluorescent 
color. The intensity, or magnitude, of the fluorescent light is read by a machine. This 
magnitude is then interpreted as an amount of the sought after protein, using a standard 
curve constructed with known concentrations. 
 
Cortisol 
Study I: Urine cortisol concentrations were determined by standard laboratory methods 
(time-resolved fluorometry - Auto Delfia Cortisol Kit, Wallac OY, PerkinElmer, Wellesley, 
MA, USA). Urine was collected from 10 PM the evening before until the first morning 
urine on both assessments days. This type of assay is similar to the ELISA procedure; 
several steps of preparation with antibodies and the sought after molecule precede the 
reading of fluorescence in a machine, and the magnitude is interpreted as the amount of the 
molecule.   
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4.5.2 Sleep 
Although disturbed sleep may be seen as part of the stress response, sleep can also be seen 
as a moderating factor. Sleep can be measured in many different ways, with both subjective 
and objective measures that obviously differ in the information gained. In this thesis, only 
self-report measures have been used. Self-report measures are practical and economical 
tools to evaluate sleep. In addition, no objective measures, but only subjective reports of 
sleep complaints are central for an insomnia diagnosis [65, 66]. Sleep diaries represent a 
core assessment component in insomnia research [170], although patients with insomnia 
generally over-estimate wake-time [171]. Nonetheless, sleep diaries have been shown to 
correlate well with objective measures [172], and self reported sleep quality is strongly 
related to total sleep time and amount of SWS [173]. 
 
4.5.2.1 Sleep diaries  
In study II, sleep related diary questions were selected from the Karolinska sleep diary 
[174]. They included bed-time and rise-time, sleep latency (“Amount of time it took you to 
fall asleep (after lights were turned off)”), sleep quality (rated on a five-point Likert-type 
scale, 1=”very bad” to 5=”very good”), whether participants felt refreshed after (1=”not at 
all refreshed”, 5=”fully refreshed”), whether they slept enough (1=”no, definitely 
insufficient”, 5=”yes, definitely sufficient”).  
 
In study IV, a full sleep diary [68] was used. It was recorded during one week at each of 
three assessment points. The sleep diary includes registration of bed time, time of falling 
asleep, length of night time awakenings, time of waking up and time of getting out of bed, 
as well as subjective sleep quality, positive and negative day-time evaluations, day-time 
activities, stress at bed time, and medications. From these data, sleep timing measures (i.e. 
sleep onset latency, wake after sleep onset, total sleep time and sleep efficiency (calculated 
as total sleep time/total time in bed)) may be calculated, and subjective diary measures used 
(i.e. sleep quality, day-time fatigue  (i.e. “On a scale 0-5, where 0 is ‘not at all’, and 5 ‘very 
much so’, rate how tired you have felt today”), and positive day-time ratings (i.e. “On a 
scale 0-5, where 0 is ‘not at all’, and 5 ‘very much so’, rate how alert/well 
functioning/happy you have felt today”). All sleep diary measures were computed as the 
mean of the daily ratings over the week. Sleep diaries are the most widely used outcome 
measures in insomnia research [175]. 
 
4.5.2.2 Insomnia Severity  
Study IV: The Insomnia Severity Index (ISI) [68] is a 7-item patient-reported outcome 
assessing the severity of initial insomnia (difficulties falling asleep), middle insomnia 
(difficulties sleeping through the night) and late insomnia (waking up too early in the 
morning); sleep satisfaction; interference of insomnia with daytime functioning; 
noticeability of sleep problems by others; and distress about sleep difficulties. A 5-point 
scale was used to rate each item, yielding a total score ranging from 0 to 28. Higher score 
indicates more severe insomnia within 4 severity categories: absence of insomnia (score of 
0-7); sub threshold insomnia (8-14); moderate insomnia (15-21) and severe insomnia (22-
28). The ISI has adequate psychometric properties and is sensitive to measuring treatment 
response [176]. 
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4.5.2.3 Measures of sleep interfering behaviors 
Study IV: A safety behavior is a strategy employed in order to prevent a feared outcome 
from occurring. Safety behaviors have been associated with impairment in sleep and 
daytime functioning in individuals with insomnia [177]. Therefore the Sleep Related 
Behaviors Questionnaire (SRBQ) was used to assess counter productive safety behaviors in 
insomnia [177]. The scale has 32 items which are scored between 1 (almost never) to 5 
(almost always), yielding a total score range of 32-160. Higher scores reflect higher levels 
of safety behaviors.  
 
Study IV: Rigidly held attitudes and beliefs about sleep play an important role in sustaining 
insomnia problems [178]. Dysfunctional Beliefs and Attitudes about Sleep (DBAS) [179] is 
a 30-item self-report measure identifying sleep disruptive cognitions (e.g. beliefs about the 
immediate and long-term negative consequences of insomnia, and beliefs about the need to 
control insomnia). Although developed as a visual analogue scale, it was transformed into a 
Likert-type scale with responses 0-10 for the use on a web-site. Scores range is 0-300, with 
higher scores indicating more maladaptive beliefs regarding sleep. 
  
4.5.2.4 Parent reports of impaired sleep 
In Study III, sleep was assessed by 4 items from the Child Behavior Checklist for Ages 6-18 
(CBCL/6-18) [180], which is a standardized questionnaire for parents to rate the frequency 
and intensity of behavioral and emotional problems exhibited by their children in the past 
six months. The CBCL/6-18 consists of 111 statements, and the parents rate each item on a 
3-point scale (0 = not true; 1= sometimes true; 2 = often true). The sleep items used in the 
present study were: “Has nightmares”, “Overtired”, “Sleeps less than other kids”, and 
“Sleep problems”. For each of the 4 sleep items, dichotomized variables were created to 
compare participants for whom parents had responded 1 (sometimes true) or 2 (often true) 
with those who had not been given a score of 1 or 2.  
 
4.5.3 Allergy 
4.5.3.1 Measures of lung function 
Study I: Spirometry was performed, including Peak Expiratory Flow (PEF) which is a 
measure of the maximum expiratory flow measured as liters/minute; Forced Expiratory 
Volume 1 second (FEV1) which is the volume expired during the first second; Vital 
Capacity (VC), the total volume that can be measured (excluding the Residual Volume 
(RV) which remains in the lungs); Forced Vital Capacity (FVC) which is when FEV1 and 
VC are measured during the same maximum expiration. PEF rate, VC and FVC were 
determined using the MasterScope direct reading spirometer (Erich Jaeger GmbH, 
Hoechberg, Germany), software version 2.53.2. Percentage predicted FEV1 was calculated 
as measured FEV1/predicted FEV1, and percentage predicted PEF was calculated as 
measured PEF/predicted PEF.  
 
Study I: Nitric Oxide (NO) was determined in oral single breath exhalations with a NIOXs, 
using standardized procedures [181] (Aerocrine AB, Solna, Sweden). 
 
Study I: Metacholin challenge test was performed using a dosimeter-controlled jet nebulizer 
Spira Electro 2 (Respiratory Care Center, Hämeenlinna, Finland). After recording the 
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baseline FEV1, the subject first inhaled saline followed by a methacholine solution. With 
the nose clipped, methacholine was inhaled for a specified number of breaths, in 
concentrations from 14.2 to a maximum cumulative dose of 7256 mg, with dose increments 
around every third minute. FEV1 was measured 2.5 min after each dose of methacholine 
and the test stopped when FEV1 had decreased by at least 20% from its post-saline value. 
The logarithmic metacholine doses were plotted against the percentage of the post-saline 
FEV1. PD20 values were calculated from the cumulative dose–response curves by linear 
interpolation and expressed as log values. 
 
4.5.3.2 Allergic symptom diaries 
Study II and IV: The diary included two types of questions concerning subjective symptoms 
of allergy phrased to cover asthma, rhinitis, and eczema respectively; e.g. “How often did 
you experience asthma [/eczema] symptoms [/from the eye and nose] today?” with response 
alternatives 0: “not at all” – 6: “all the time”; and “Have you been troubled by wheezing 
[/itching eczema/symptoms from eyes and nose/] during the night or morning?” with 
response alternatives 0: “not at all troubled” – 3: “seriously troubled”. The latter questions 
were also phrased to cover symptoms in the morning and evening, respectively. Individual 
questions were combined to represent symptoms of asthma, eczema and rhinitis, 
respectively.  
 
4.5.3.3 Parent reports 
Study III: To evaluate presence of asthma, rhinitis and eczema, we used questions derived 
from the International Study of Asthma and Allergy in Childhood (ISAAC) [182]: “Has 
your child ever had asthma” (yes/no) and “Has your child ever had itchy eyes and runny 
nose” (allergic rhinitis, yes/no) along with questions on recurrent itchy rash on arms and 
legs, face and abdomen (eczema, yes/no). 
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5  RESULTS 
 
5.1 PAPER I - CHANGES IN IMMUNE REGULATION IN RESPONSE TO 
EXAMINATION STRESS IN ATOPIC AND HEALTHY INDIVIDUALS. 
The aim of paper I was to increase the understanding of the effects of a brief naturalistic 
stressor particularly on allergy-relevant immune-parameters, and outcomes associated with 
regulation of the allergic inflammation (numbers of blood cells such as regulatory T-cells 
and NK-cells) and allergic aggravation (as measured by exhaled NO and lung function). We 
hypothesized that stress would be accompanied by a decrease in the Th1/Th2 balance and 
that this effect would be larger in atopic subjects. 
The hypothesis that the Th1/Th2 balance would decrease in response to stress, 
particularly in atopic participants, was confirmed; the IFN-γ/IL-4, IL-2/IL-4 and IL-2/IL-5 
ratios were significantly reduced in atopic students during stress.  
The proportion of NK cells was significantly lower in atopics compared with controls 
at the low-stress phase. Interestingly, the proportion of NK cells further decreased in 
atopics, but not in controls, during the stress phase. Both atopic and non-atopic participants 
also had increases in regulatory T cells at the time of the exam. 
Atopic individuals with asthma exhaled significantly more NO than control subjects, 
and control subjects only responded with a small but significant reduction in exhaled NO in 
response to stress. Also, during stress the FEV1 value increased slightly but significantly in 
the group of controls, but not in the group of atopic participants with asthma. 
 
5.2 PAPER II - EFFECTS OF EXAMINATION STRESS ON PSYCHOLOGICAL 
RESPONSES, SLEEP AND ALLERGIC SYMPTOMS IN ATOPIC AND 
NON-ATOPIC STUDENTS 
The aims of this paper was to compare responses between atopic and non-atopic individuals 
to a major examination, and to characterize which changes in sleep, affect, self-rated health 
(SRH) and allergic symptoms are elicited by this brief naturalistic stressor.  
For both atopic and non-atopic students, tension, anxiety, and depression deteriorated in 
response to examination, as did sleep latency and sleep quality. Overall, atopics were more 
tense, had more anxiety, longer sleep latencies, and were less well rested than non-atopics. 
Non-atopic students rose from bed later during the examination period. In response to 
examination, atopic students reported increased frequency of stress behaviors (e.g. eating 
fast), while decreased stress behaviors were reported by non-atopic students. Allergic 
symptoms were not affected. 
 
5.2.1 Additional analyses 
5.2.1.1 Self rated health 
Lately, there has been a growing interest in subjective health perception (i.e. SRH), as it is a 
strong and independent predictor of health and mortality [183, 184]. Little is known about 
changes in perceived health in a response to stress. The Swedish council on technology 
assessment in health care has concluded that SRH should be included in studies of allergic 
diseases, such as asthma[185]. In a recent thesis, it was shown that pro-inflammatory 
cytokines are related to poorer self-rated health [186]. 
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Self-rated health in this study was measured with SRH-5 [187] i.e. the question “How 
would you rate your general health?”, rated on a five-point scale ranging from 1 – ‘very 
good’, to 5 – ‘very bad’.  
An ANOVA showed that SRH (see table 5.2) did not differ between the groups but was 
negatively affected by stress in both atopic and non-atopic participants (F(1, 36)=13.412, 
p<.001, ηp2=0.271). 
 
Table 5.2. Mean SRH rating according to atopic status and condition. 
  Study period Examination period 
  Mean (SD) Mean (SD) 
Self rated health Atopic participants 1.7 (0.7) 2.0 (0.7) 
 Non-atopic participants  1.4 (0.5) 1.7 (0.6) 
 
 
 
5.3 PAPER III - DEVELOPMENT OF ALLERGIES AND SLEEP 
DISTURBANCES IN CHILDHOOD AND ADOLESCENCE 
The aim of paper III was to investigate whether aspects of disturbed sleep in childhood (age 
8-9) predicts development of allergy in adolescence (age 13-14), and vice versa; if presence 
of allergy in childhood increases the risk of developing sleep problems in adolescence. 
Being overtired at age 8-9 was associated with an increased risk [OR; 95% CI (2.59; 
1.31-5.11)] to develop rhinitis at age 13-14, even when controlling for sex, previous rhinitis, 
socioeconomic status (SES), birth weight, and other sleep problems at age 8-9. Likewise, 
asthma at age 8-9 was an independent risk-factor for being overtired at age 13-14 [OR; 95% 
CI (2.64; 1.44-4.84)], controlling for sex, previous overtiredness, SES, birth weight, and 
asthma at age 8-9. Associations were also found for being overtired at 8-9 with asthma at 
13-14 [OR; 95% CI (3.21; 1.84-5.60)], asthma at 8-9 with short sleep at 13-14 [OR; 95% CI 
(2.63; 1.34-5.18)], asthma at 8-9 with trouble sleeping at 13-14 [OR; 95% CI (2.33; 1.01-
5.42)], rhinitis at 8-9 with trouble sleeping at 13-14 [OR; 95% CI (2.52; 1.26-5.03)], and 
eczema at 8-9 with short sleep at 13-14 [OR; 95% CI (1.85; 1.18-2.91)]. However, these 
associations disappeared after controlling for other factors, indicating associative 
predictions, rather than possible causal relationships. 
 
5.4 STUDY IV - EFFICACY OF A BEHAVIORAL SELF-HELP TREATMENT 
WITH OR WITHOUT THERAPIST GUIDANCE FOR INSOMNIA WITH CO-
MORBID PROBLEMS 
 
The aim of this study was to evaluate the efficacy of a cognitive behaviorally based self-
help book to treat insomnia in individuals with co-morbid problems, including allergies, and 
the effect of adding brief therapist telephone support. 
The hypothesis that the self-help intervention would improve patients’ sleep was 
largely confirmed. Intention-to-treat analyses showed both self-help groups improving 
significantly from pre to post treatment in sleep timing, subjective sleep measures and 
daytime functioning, compared to waiting list. For example, bibliotherapy with and without 
support gave shorter sleep onset latency (improvement, minutes [95% CI]), 35.4 [24.2 to 
46.6], and 20.6 [10.6 to 30.6] respectively, and support gave a higher remission rate (61.4%, 
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p<.001), than bibliotherapy alone (24.4%). In the two groups receiving bibliotherapeutic 
treatment, the group receiving telephone support improved more on sleep related measures 
than the group that did not. Improvements were not seen in the control group (sleep onset 
latency 4.6 minutes [-1.5 to 10.7] shorter, and remission rate 2.3%). Improved sleep in the 
treatment groups was generally maintained at follow-up, although some differences 
between the treatment groups had diminished. Larger number of co-morbid problems was 
negatively correlated with outcome post treatment, but not at follow up. Only nightmares 
affected outcome negatively, whereas other co-morbid problems, including allergies, did 
not.  
 
5.4.1 Additional analyses 
Additional analyses were performed to investigate how allergy affected sleep, and how 
sleep affected allergic symptoms. 
First: analyses showed that allergic participants made up a substantial proportion of the 
sample; a total of 77 participants (57.9%) were diagnosed as having one or more allergic 
problems. Allergic participants were distributed evenly between the groups (see table 5.4). 
 
Table 5.4. Number of allergic participants according to study group. 
 
 
Bibliotherapy  
with support 
(n=44) 
Bibliotherapy  
(n=45) 
Waiting list 
control 
(n=44) 
Total 
(N=133) 
P Valuea  
Allergies n (%) 29 (65.9%) 24 (53.3%) 24 (54.5%) 77 (57.9%) .42 
 
Second: The groups did not differ in insomnia severity at pre treatment assessment, nor 
at post treatment or three month follow up assessment. Comparing the effect of treatment 
for allergic participants and non-allergic participants (including participants with other co-
morbid problems), there was no interaction effect (F(1.879,148.414)=1.175, p=.310, ηp2=.015), 
i.e. the effect of treatment did not differ between these two groups. (See figure 5.4. 1) 
Third: As seen in figure 5.4.2., numeric decreases (i.e. improvements) in allergic 
symptoms were observed at the three-month follow-up assessment (fu3), compared to the 
pre-treatment assessment (pre), and post-treatment assessment (post). However, when 
ANOVAs were conducted to find out if allergic symptom scores differed between the three 
time points, a main effect was found only for rhinitis symptoms (F(2, 134)= 6.379, p=.002,  
ηp2 = 0.087). Pairwise comparisons revealed no difference between pre and post assessment 
(p=.333), but there were significant differences between pre and fu3 (p=.008), and a trend 
between post and fu3 (p=.065). I.e. significantly less rhinitis symptoms were reported at 
fu3. 
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Figure 5.4.1. Mean scores for insomnia severity at pre treatment assessment (Pre), post 
treatment assessment (Post), and three-month follow-up assessment (Fu3) for treated 
participants, divided into group according to allergic status.  
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Figure 5.4.2. Mean scores for allergic symptoms at pre treatment assessment (Pre), post 
treatment assessment (Post), and three-month follow-up assessment (Fu3), for allergic 
particpants only. 
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6 GENERAL DISCUSSION 
In this thesis, the relations between stress and allergy, and sleep and allergy have been 
investigated. The findings are discussed, particularly with respect to the allostasis model and 
allergic disease. 
 
6.1 INITIAL QUESTIONS AND NEW FINDINGS PUT IN CONTEXT 
I set out on this project since I was puzzled by the observation by many clinicians and 
allergic patients that stress aggravates allergic symptoms, and the concurrent scientific 
findings of a relationship between psychosocial stress and asthma [188] and atopic 
dermatitis [112]. I was curious about which mechanisms could perhaps explain such 
observations; In what ways may stress be involved in the expression of atopic disease? 
What psychobiological mechanisms might be involved? Could it be that parts of the stress 
process might differ between atopic and non-atopic individuals? 
 
6.1.1.1 The impact of stress on allergic symptoms 
In the first study, results showed that acute stress perception and stress responses – changes 
in allergy relevant immune parameters as well as emotional and behavioral responses 
including sleep – did differ between atopic and non-atopic individuals. The immune 
changes seen in atopic participants could increase expression of allergic symptoms. The 
emotional and behavioral response in both atopic and non-atopic participants could be 
conceptualized as increases in allostatic load. Interestingly, allergic symptoms did not 
increase, which raised new questions about the specific circumstances during stress that lead 
to increases in allergic symptoms.  
Around the time data was collected for the first study, a series of studies were 
published, showing that a brief naturalistic stressful condition produced greater allergy 
related immune response to challenge [103], and that different types of acute stressors, such 
as computer stress and mobile telephone ringing, enhanced skin wheal responses in atopic 
individuals [104, 107]. However, there were also studies, which like our own showed 
allergy relevant changes in immune function, but not in symptom expression such as lung 
function [116]. A few years later, Chen & Miller presented a model proposing that immune 
changes during stress may not cause asthma symptoms, but rather set the stage for increased 
symptoms if there is concomitant exposure to allergens [101]. Support for this model has 
also come later with studies similar to those of Kimata (above), but with a more 
conventional stress inducing task (the Trier Social Stress Test) [189]. Since our participants 
were not exposed to allergens during the course of the study, this could explain the lack of 
changes in allergic symptoms. That being said, it should be kept in mind that in animals, 
and possibly also in humans, allergic or allergy relevant immunological processes can be 
behaviorally conditioned to and subsequently elicited by exposure to a neutral stimulus such 
as a taste [190-192].   
 
6.1.1.2 Acute and chronic stress in allergy 
Also the type of stressor under study could perhaps account for some differences in allergic 
symptom expression. From a general allostasis perspective, short term stress is seen as an 
adaptive response which enhances many functions central to survival, including immune 
function [45]. Chronic stress, on the other hand, has been suggested to suppress immune 
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function [13]. However, it is also noted that enhanced immune function may be detrimental 
under certain conditions, for instance in autoimmune diseases or allergies, whereas 
suppression of at least some aspects of immune function may be beneficial in these 
circumstances [193]. In line, a recent study showed that experiencing a very powerful 
stressor (loss of a child) actually decreased the risk of developing amyotrophic lateral 
sclerosis (ALS) [194], something that could possibly be explained as following a stress-
induced tilt in immunological balance. 
Although there are studies that have shown improvements in some allergic symptoms 
in response to acute stressors [e.g. asthma 195], acute stress does not seem to necessarily be 
beneficial in the case of allergy. For instance, Sandberg et al. [114] showed that acute life 
stress significantly increased the risk of asthma exacerbations, and that this risk was further 
increased, and onset of exacerbations hastened, if the acute stressor occurred on top of 
chronic stress [114]. Chronic stress as such entailed no increased risk of exacerbations. In 
line, a recent study by Marin et al. compared asthmatic children with high or low chronic 
family stress. Children with high chronic family stress had increased production of Th2-
cytokines (IL-4, IL-5), and Th1-cytokines (IFN-γ) (from peripheral blood mononuclear 
cells) in response to an acute stressor resulting in a Th2 dominance. The combination of 
acute and chronic stress was also associated with increased asthma symptoms. In contrast to 
the Sandberg study, there was no relationship between acute events and cytokine production 
in the absence of chronic stress [196].  
In an animal model of allergic asthma, airway cytokine responses to acute and chronic stress 
differed between asthmatic and non-asthmatic animals. Kang et al. shoved that acute stress 
produced a Th2 predominance in allergic animals (by increasing IL-4 and decreasing IFN-γ 
levels), but a Th1 predominance in non-allergic ones (by decreasing IL-4 levels). Chronic 
stress on the other hand, produced a Th1 predominance (by decreasing cytokine levels 
overall) in both asthmatic and non-asthmatic animals. Kang et al. conclude that “These 
findings suggest that a significant shift toward Th2 predominance in asthmatic mice under 
acute stress may be a mechanism underlying exacerbation of asthma” [197]. 
There may be a problem with the terminology here; acute stress for the mice in the 
Kang study was one hour of exposure to bright light in an open box combined with mild 
rotation, and chronic stress was the same stressor but one hour a day for four days. Acute 
stress for the children in the Sandberg and Marin studies was “specific events with discrete 
onset and offset” [196]. However, most were major life events such as loss of important 
social relations; a relative passing away, a close friend moving to another city, or a parent 
being laid off. Chronic stress in the Sandberg study was ongoing social problems such as 
drug abuse, child abuse or chronic illness of a close family member, and in the Marin study 
“the quality of interpersonal relationships among family members”. I do not see that the 
label acute time limited stressor as used in the Segerstrom meta analysis would be the best 
to describe the acute onset events used in either the Marin or the Sandberg studies. From a 
child’s experience, are these events really discrete and short-term. Since loss is major 
stressor, I would be inclined to suggest that they would perhaps be better described as 
stressful event sequences, i.e. one major event, such as the loss of a spouse or a major 
natural disaster, gives rise to subsequent related challenges.   
Although the nature of stressors varied across studies, the effect is quite consistent and 
in line with other studies of both acute laboratory stressors [e.g. 102], brief naturalistic 
stressors [e.g. 103] and chronic stressors, such as low socio-economic status [e.g. 198, 199]. 
Thus, many types of stress do seem to promote a Th2 shift and (likely in case of exposure to 
allergen) may increase allergic symptoms in allergic individuals.  
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Can a Th2-shift then be seen as a sign of allostatic load? Perhaps that could be the case 
in allergic individuals. A Th2-shift may not necessarily be the “normal” effect of stress, 
although some studies have seen such a shift also in non-allergic individuals in response to 
stress [200] and disturbed sleep [142]. However, other studies find that a Th1/Th2 skew in 
response to stress is typical of allergic disease, and not a general response to stress [196]. 
 
6.1.1.3 Allergy as an expression of allostatic load 
Based on the original conception of allostatic load, several biological markers have been 
suggested, and combined into a 10-item allostatic load index (ALI) [201]. This “was a 
cumulative index that took into account various possible stress responses involving blood 
pressure, glucose metabolism (and consequent obesity), inflammation markers, and 
hormonal responses. It measured ‘‘primary’’ biological parameters (including the hormone 
and inflammation markers) and secondary health outcomes (the cardiovascular and 
metabolic risk factors). The index consisted of systolic blood pressure (SBP), diastolicblood 
pressure (DBP), waist to hip ratio (WHR), total cholesterol (TC), glycosylated haemoglobin 
(HbAlc), high density lipoprotein (HDL) cholesterol, dehydroepiandrosterone (sodium) 
sulphate (DHEA-S), urinary cortisol, urinary norepinephrine (NE), and urinary epinephrine 
(EPIN)”. [202] There is obviously a very clear connection from these measures to 
Cardiovascular disease (CVD), but the relation to allergic disease is more obscure.  
However, from another angle, in study I (paper II), we found that atopic individuals 
reported more stress (or Type A) behaviors during the stressed period, whereas the non-
atopic students reported less such behaviors [203], an aspect we are not aware has been 
studied before in relation to allergy. Type A behavior pattern has previously been strongly 
linked to CVD [204]. Interestingly, a relation between allergies and CVD has long been 
hypothesized [205], but has been explained as side effects by drugs used to treat asthma. 
However, recent findings suggest that asthma and cardiovascular risk could be linked by 
obesity and negative affect [206] as well as by pro-inflammatory mechanisms [207-209]. 
Recall from above that pro-inflammatory cytokines were also seen in response to chronic 
stress in studies of both mice [197] and men [196]. In addition, they are involved in chronic 
allergic inflammation [210]. A similar hypothesis has been put forward which argues that 
repeated acute or chronic psychologically stressful states may cause inflammatory processes 
that lead to CVD and type 2 diabetes [211]. 
Now, although the place of Th2 dominance is unclear, it may seem like a logical step to 
link all these findings and suggest that the connections between stress and allergies may also 
be mediated by an inflammatory pathway, rather than by the classical allostatic load 
measures (see above). Indeed, Priftis et al. [88] recently suggested precisely this; that 
allergy is to be conceptualized as a form of allostatic (or as they would prefer, cacostatic) 
load, where elevated pro-inflammatory cytokines, such as TNF-α, IL-1, and IL-6 are the 
principal conduits, which may induce a state of hyporesponsiveness of the HPA axis, 
whereby attenuated cortisol secretion and exacerbation of allergic airway inflammation 
ensue.  
 
6.1.1.4 Atopy as a stressor – increasing allostatic load 
Although perceived stress in relation to an experimental or quasi-experimental stressor has 
often not been shown to differ between allergic and non-allergic participants [102, 120], in 
study I, we found stress levels to be elevated in atopic students as compared to non-atopic 
students as a response to a brief naturalistic stressor [212].  
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Atopic participants in study I had some signs of higher allostatic load than the non-
atopic ones; they had higher levels of anxiety and depressive symptoms, and altered sleep 
patterns. In line, Liu et al. [103] also found students' anxiety and depression scores to be 
significantly higher during an examination period. 
Lower cortisol levels were seen in atopic participants. This could be seen as an 
indication of a lower level of allostatic load. However, an attenuated activity and/or 
responsiveness of the HPA axis is consistently shown in allergic patients [213], and has 
been shown to be related to the severity of allergic inflammation [127]. Indeed, Angelica 
Buske-Kirschbaum [214] finds that hyporesponsiveness is a key feature of atopic disease 
(with previous hyperresponsiveness in infancy).  
In addition, Hellhammer et al. [215] suggest that there may be two major subtypes of 
the HPA-axis response to stress, where one is hypocortisolemy. They found that the 
hypocortisolemic subjects had a lower allostatic load (as measured with an AL-index like 
the one described above) but that they scored higher on measures of depression, perceived 
stress, and physical complaints, which is in line with the findings among our atopic 
participants. 
It is also possible that the more negative emotional states could be an effect of 
underlying endocrine and immunological deviations, including inflammation, adding to the 
allostatic burden. Thus, one possible interpretation of available data is that allergic disease – 
even when not actively expressed in allergic symptoms (for instance most of the atopic 
participants in study I had few allergic symptoms during the course of the study) – equals 
increased allostatic load. It is possible that a negative circle could ensue, where 
inflammation and subsequent negative mental states would constitute an additional burden 
for atopics compared to non-atopics in the face of stressors, adding to allostatic load causing 
more negative feelings adding to the negative effects of a future stressor, resulting in higher 
allostatic load and eventually allostatic overload, for instance expression of (allergic) 
disease or psychopathology such as depression [31]. In line, connections between allergy 
and increased levels of psychological distress have been reported repeatedly [e.g. 117, 122, 
216, 217], and recently also a connection between allergy and suicide [124, 218]. 
 
6.1.1.5 Allergy and sleep 
In study I, both atopic and non-atopic students experienced worse sleep quality during the 
examination period, which is in line with other studies on the effect of stress on sleep [e.g. 
219]. Further, sleep latency and feelings of being well rested in the morning differed 
between atopic and non-atopic participants; atopic students took longer to fall asleep, and 
felt less well rested, although time in bed did not differ between the groups. The prolonged 
sleep latency during stress is in line with the fact that behavioral responses to stressors 
includes increased arousal and wakening [220], however, the fact that it only occurred in 
atopic students could be seen as support for the hypothesis that allergy increases allostatic 
load.  
The connection between allergy and impaired sleep seen in this thesis can be seen as a 
partial explanation for the previously mentioned differences in acute stress levels between 
atopics and non-atopics. Disturbed sleep is part of the stress response, and contributes to 
increased levels of stress and discomfort, which could be expected to lower the threshold for 
experiencing stress, or increase stress perception reactivity. If the effects of stress are 
cumulative, as the allostasis model suggests, then an event might be experienced as more 
stressful if you already have a stress load to begin with (the straw that brakes the camel’s 
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back...). Thus, non-restorative sleep could add to the negative circle described above, with 
impaired recovery and increased allostatic load in atopic patients. In fact, a very recent 
review puts forward the hypothesis that allergic rhinitis leads to mood and anxiety disorders 
and an increased risk of suicide, via sleep impairment [221]. 
 
6.1.1.6 Impact of sleep on the development of allergy 
Study I then showed increased levels of disturbed sleep in our participants with atopy [203]. 
This has also been seen in several other studies [e.g. 135, 136-140]. In addition, several 
recent finding also support a connection between stress and disturbed sleep [e.g. 57, 58].  
With recent studies indicating an etiological connection between stress in infancy and 
childhood, and later development of atopic disease [77, 132], new questions arose; 
specifically about the role of stress in the development of atopic disease. Since sleep is 
important for maintaining homeostasis, disturbed sleep can be considered a stressor in and 
of itself [30], which, as we have seen above, can sometimes lead to exacerbations of allergic 
symptoms. In addition, disturbed sleep has been associated with a Th2 cytokine shift [142]. 
We therefore set out to find an epidemiological material where we could study whether 
impaired sleep could be related to later development of allergy, and vice versa. In paper III, 
we found that an indicator of impaired sleep (fatigue) was related to later development of 
rhinitis. However, when controlling for confounding factors such as gender, birth weight, 
and socioeconomic status, other sleep measures could not predict the development of 
allergic disease, even though cross sectional relations were found. This could be a problem 
of sufficient power in the study, since for instance only 60 children developed asthma 
between the ages of 8-9 and 13-14. 
Another explanation could be that parents are better at noticing high levels of fatigue (a 
main characteristic of disturbed sleep) rather than disturbed sleep itself, particularly since 
parents are more likely to be around their children while they are awake compared to when 
they are sleeping. I.e. the reliability of this variable may be better than that of the other 
variables. However, as fatigue is also part of the sickness response seen in inflammation 
[141], it could also be a “true” effect of fatigue – i.e. fatigue is not necessarily a result of 
impaired sleep.  
 
6.1.1.7 Impact of allergy on development of sleep problems 
We also found that asthma was related to more fatigue at a later age. In line with the 
reasoning above, it is possible that asthma – well known to disturb sleep acutely – could 
result in both worse sleep and fatigue across time. The connection could be mediated partly 
through the effects of annoying symptoms; e.g. trouble breathing prevents you from dozing 
off. However, it could also be an effect of alterations in the endocrine and the immune 
systems seen in atopic individuals. For instance, several of the Th2 cytokines which are 
over expressed in atopy are also known to inhibit sleep [54].  
Many allergic individuals continue to have sleep problems despite adequate treatment 
for their allergies [148]. One explanation of this could be if treatment reduces symptoms, 
but does not clear the underlying physiological dysfunction. The person could then for 
instance be left with a low grade inflammation, similar to what is seen in depression [206], 
which may have negative consequences for sleep. An alternative explanation for the 
remaining sleep problems in these individuals could be that the acute sleep problems 
resulting from the symptoms, have developed into insomnia, through the traditional 
pathways suggested in the CBT model for insomnia; heightened arousal, and cognitive 
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changes such as more focus on sleep and the consequences of impaired sleep, and 
dysfunctional behavioral strategies to handle fatigue and night-time waking [68].   
 
6.1.1.8 Improving sleep in allergic individuals 
With all these possible pathways linking allergy and impaired sleep, it seemed like a logical 
final step of this project to develop and evaluate a treatment for impaired sleep (insomnia), 
to investigate whether such treatment could improve sleep for individuals with allergy and 
insomnia. Paper IV presents the general results from a randomized controlled trial of a CBT 
treatment for insomnia and shows that sleep can be improved in individuals with insomnia, 
also if they have co-morbid problems (including allergies). Sub-analyses showed that sleep 
improved as much for allergic participants as it did for participants without allergies. 
Indeed, additional analyses of the data showed that over half the participants in the study 
had allergies, and that rhinitis symptoms decreased significantly at three-month follow up. 
Thus, insomnia severity improved after treatment, and some time later allergic symptoms 
decreased. In line with the hypothesis that impaired sleep increases allostatic load, one 
could hypothesize that improved sleep, over the course of some time, had lowered the 
cumulative allostatic load, leading to less allergic symptoms. 
 
6.2 LIMITATIONS AND STRENGTHS 
A general problem for studies on stress is the lack of a comprehensive stress theory to put 
findings into a broader perspective. In this thesis, one of the “micro models” – the allostasis 
model – has been used. A micro model is certainly better than no model, but they all still 
lack the ability to predict aspects of the whole stress process. However, refining micro 
models can eventually lead to the development of a comprehensive theory that may be able 
to better define aspects such as what is a stressor (and for whom?), what constitutes a stress 
response, and not least how and when stress may be advantageous or deleterious. The 
CATS (see under Models and Theories of Stress) is an attempt to put together findings from 
different areas, and is worthy of more attention in future research. Another aspect is that 
even a comprehensive model is not The Final Model, since research and new research 
methods give rise to new knowledge partly by rejecting previous knowledge and theories. 
Clearly, to explore the links between stress, sleep and allergy, an interdisciplinary approach 
is warranted. The present project was conducted in close and fruitful collaboration between 
researchers trained in e.g. psychology, medicine, physiology, and sleep medicine, and 
utilized methods stemming from different methodological research traditions.  
Some specific limitations of the studies are also present. In the first study (paper I and 
II), we did include many allergy relevant immune measures. However, we did not include 
measures of allergy relevant functional measures of the immune cells, but only number of 
cells and amount of cytokines. The biological significance of these changes is unknown. 
The participants were not exposed to allergen during the course of the study. In one way, 
this is a limitation since we cannot say anything about how stress modulates the response to 
antigen. However, it is also a strength, in that we do show allergy relevant immune changes 
occurring despite the absence of allergen. Another limitation is that the study was done with 
students with well managed allergy only. The generalizability of the results to other groups, 
including for instance other age groups and individuals with more severe allergy is limited. 
In addition, for paper I, we did not use any measure of well-being or positive affect, which 
has been shown to differ between allergic and non- allergic individuals [222] and account 
for differences in immune response [223]. In addition, no measure of chronic stress was 
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used, so we cannot say anything about the possible additional impact of chronic stress in the 
background of this brief naturalistic stressor. Further, the order of observation was not 
balanced; i.e. all students were observed first during the non-examination period and second 
during the examination period. Strengths of the study was the thorough screening of 
participants including medical evaluations, the inclusion of measures of lung function, 
airway inflammation, stress hormones, allergic symptoms, and the inclusion of non-atopic 
individuals as a control group.  
In study III no measure of stress was included, only measures of impaired sleep. 
Although impaired sleep can be seen as an indicator of an ongoing stress response, 
including a stress measure would have made possible another set of calculations to account 
for additive or interactive effects of stress and sleep on the development of allergic 
problems. In addition, the study did not include optimal questions of sleep disturbances. In 
the same vicinity, at least in Swedish, “overtired” can have a connotation of being unable to 
wind down. It is thus possible that the connections seen were mediated by other factors than 
impaired sleep. Also, despite the population approach, the statistical power was not enough 
to perform interesting sub-analyses, such as the relative importance of genetic and 
environmental influences using basic twin analyses. Further, our data indicate causal 
relationships between sleep and allergy, but we cannot exclude the possibility that some 
third factor is involved and cause both these connections. For instance, there may be 
underlying alterations in the function of the stress-systems (e.g. HPA-axis and SAM-
systems) that are important for both the development of allergies and sleep disturbances. 
Further, no control was done for other diseases, therefore it cannot be excluded that fatigue 
is really predictive of all-cause morbidity, rather than specifically for allergic disease (or 
even more specifically: rhinitis). Another limitation is that we only used parent-report data. 
Although parents are often the best available informants for young children, the children in 
this study were, especially at the second assessment, old enough to answer for themselves, 
and their answers may have been more reliable than their parent’s. The presence of allergic 
disease was also determined using parent reports of allergic symptoms. Although this is a 
limitation, the questions used were from a large world-wide multi center study of 
prevalence of allergic diseases (International Study of Asthma and Allergy in Childhood – 
ISAAC), and can thus be directly compared. Some strengths with the study is its 
prospective design, which does allow for estimates of prediction, and its inclusion of 
enough subjects to find new cases of allergy between the ages of 8-9 and 13-14.  
Finally, in study IV interviewers were not blinded to treatment condition, and therefore, 
interview data may be biased. On the other hand, all questionnaires were filled out on the 
internet, a feature that has been suggested to increase participants’ willingness to reveal 
unpleasant information, such as not improving with treatment, by reducing the impact of 
social desirability. Another limitation is the timing of measurements. Since pre- and post 
assessments took place during spring and early summer, whereas the three-month follow-up 
assessment took place in October, it is not inconceivable that the decrease in allergic 
symptoms is a function of time of year, rather than an effect of improved sleep. To be able 
to shed light on this question, it would have been better to include participants and to time 
measurements with regards to allergen exposure peaks. Ideally, pre-treatment assessments 
would have been done one spring, after which treatment could be implemented, and then a 
follow up assessment could take place again next spring. It would then have been possible 
to see how allergic symptoms may impact sleep improvements or vice versa in the longer 
term. If improvements that could not be accounted for by lower levels of pollen were seen 
in allergic symptoms, this would have given stronger support for an impact of sleep via the 
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inflammatory pathway in allergy. In addition, including measures of self-rated health (SRH) 
would also have been interesting, to provide a global outcome measure of high predictive 
validity. In this study, allergic disease was determined using a questionnaire. Although it 
was screened by an allergy specialist, we cannot exclude misclassification. In addition, no 
biological measures were included, so the biological correlates of the treatment effects are 
shrouded in mystery. However, among strengths of the study can be mentioned its  
randomized and controlled design, and that it included a comparably large number of 
participants, out of whom a substantial proportion (almost 60%) were allergic and many had 
other co-morbidities.  
 
6.3 FUTURE CONSIDERATIONS 
Although clinical observations of stress related exacerbations of allergic symptoms and 
epidemiological studies finding relations between psychosocial stress and allergy have been 
a ground for investigating mechanisms for such relationships, it is unknown what 
proportion of allergic patients experiences this relation. Systematic studies would be needed 
to find that out. In addition, it may be that individuals’ own experience of this relationship is 
one factor that could explain differences in stress responses. Testing that hypothesis could 
be done in experimental studies. 
Trying to get a grip of the research on stress, I have been struck by the lack of 
agreement over many things. Future studies need to clearly specify not just how the word 
stress is used (if at all since other suggestions have been provided that may be more 
accurate), and what stage(s) in a stress process are studied. Although many stress 
researchers are beginning to do so, increased efforts should be made as to clarify whether 
stressors under study are acute or chronic, or combined. In addition, studies are needed that 
can clarify whether for instance emotional expressions are a cause for, or an effect of stress 
(or both). It may be that a distinction between primary and secondary stressors is a fruitful 
way to go, as suggested by for instance Pearlin [224]. In addition, which individual 
differences are important in determining responses to stress is a question still far from 
having a definite answer. There is obviously still much work needed in this area.  
I was also surprised by the lack of agreement of the concept of “disturbed sleep”. It 
seems to include at least three different kinds of “disturbed sleep”. 1) Unnecessary or 
involuntary sleep deprivation; one is kept awake, or sleep is repeatedly interrupted, even 
though sleep pressure is high. This would include sleep fragmentation from sleep apnea or 
noise (heavy traffic, airplanes and so forth), but also being kept awake as part of a sleep 
deprivation experiment. 2) “Necessary” sleep deprivation; there is a stressor or changed 
circumstance that is a “reasonable” reason one does not sleep; for instance important work 
deadlines, difficult decisions that need to be made, or little children that need tending. 3) 
Insomnia; one gets stressed from being awake at night and from feeling tired during the day.  
It does not seem reasonable that these kinds of disturbed sleep would have the same 
effect; not least because they are perhaps topologically alike, but contextually distinct. 
Although the argument can be made that it is the number of hours or minutes of shortened 
sleep that is crucial for the effects, I believe the understanding of the effects of “disturbed 
sleep” would benefit from taking such differences into account.  
Moreover, different types of allergies may be affected in partly different ways. A 
distinction may be needed between the different types of expression (asthma, rhinitis and 
eczema), since some studies have shown differences in e.g. anxiety levels comparing atopic 
dermatitis and allergic rhinitis [225]. In addition, atopic and non-atopic background for the 
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same or similar disease expressions (e.g. atopic vs. non-atopic asthma, rhinitis and 
dermatitis) could be of relevance. For instance, differences have been seen in allergic and 
non-allergic rhinitis in the risk of developing sleep apnea [226], and impairment in quality 
of life has been shown to differ between different types of non-allergic rhinitis [227].  
In addition to studying these aspects one at a time, they need to be studied in concert, to 
improve our understanding of their inter-relations. More efforts are needed to clarify 
individual differences in the responses to stressors, especially with respect to allergy. Not all 
persons with atopy have the same amount of Th2-tilt; how can these differences be 
predicted? Do we need to take more psychologically oriented or other models into account, 
or can enough of this be explained by differences on a physiological level? I would also like 
to see more studies investigating the relevance of the allostasis model in allergic disease. I 
believe the model would need adaptation to fit the allergic diseases better. For instance, can 
a Th2-shift be considered allostatic load? Perhaps other measures of allostatic load than 
those commonly used would apply for individuals who are not primarily pre-disposed for 
the metabolic changes suggested? Finally, although the Chen model of allergic symptoms in 
relation to stress is very appealing, it is not sufficiently supported for symptoms other than 
asthma, so more work is needed there as well. 
In addition, since sleep is often disturbed in allergy, the present findings suggest a need 
for treating sleep problems in individuals with allergy, and shows that this can be done. 
Future studies, however, are needed to confirm treatment effects, and to test if successful 
treatment of stress and/or sleep may decrease symptom expression. In addition, studies need 
to test the hypothesis that treatment of sleep disturbances, or psychological distress in 
children with atopic disposition could diminish the risk for developing allergic disease 
 
6.4 CONCLUSIONS 
This thesis presents increased support for, and suggests an expansion of previous findings of 
stress related immune changes to involve also increases in regulatory T-cells. It provides 
increased support for the involvement of stress in allergy relevant immune changes in atopic 
individuals, as well as for increased levels of psychological distress, impaired sleep and 
increased stress behaviors in atopic individuals as compared to non-atopics, and suggests 
these changes to be a sign of increased allostatic load in atopics. In addition, the thesis 
replicates previous findings of cross-sectional relations between impaired sleep and allergic 
symptoms, but also presents preliminary evidence that aspects of impaired sleep act as risk 
factors in the development of allergy, and vice versa. Finally, it shows for the first time that 
individuals with insomnia, despite presence of allergies and other co-morbidities, can be 
successfully treated using a self-help CBT treatment for insomnia. Interestingly, three 
months after improvements in insomnia severity, improvements in allergic symptoms were 
seen. Altogether, the thesis confirms a coupling between stress, sleep, and allergy and 
suggests future studies to test if successful treatment of stress and sleep may decrease 
symptom expression or even diminish the risk for developing allergic disease.  
 
 
 
 40 
7 SAMMANFATTNING PÅ SVENSKA 
På senare år har förekomsten av allergiska sjukdomar ökat dramatiskt i västvärlden och 
omkring 30% av Sveriges befolkning är idag drabbade av allergi. Vad denna ökning beror 
på är oklart, men beteendefaktorer som stress och sömn tros vara några av orsakerna. Även 
stress är ett vanligt problem idag, och stress kan förändra bl.a. immunsystemets aktivitet och 
funktion. Sömn, å andra sidan, är viktig för återhämtning, och störd sömn kan fungera som 
en stressor i sig. Allergiska patienter uppger ofta att allergiska symptom ökar i samband 
med stress. Dessutom lider många allergiker av trötthet och störd sömn, särskilt vid 
exponering för allergen. Det är dock fortfarande oklart hur sambanden mellan stress, sömn 
och allergi ser ut. Det övergripande målet för denna avhandling var därför att öka 
kunskapen kring dessa samband. 
Avhandlingen baseras på tre studier, varav den första är kvasiexperimentell. Studenter 
med och utan atopi observerades under en vanlig studieperiod och under en 
tentamensperiod (artikel I och II). Vid båda tillfällena fick studenterna bl.a. genomgå 
lungfunktionstestning och lämna blodprov. De fick också fylla i frågeformulär och 
dagböcker om psykologiska och allergiska symptom samt om sömn. Resultaten visar att 
både atopiska och icke-atopiska studenter var mer stressade under tentamensperioden, och 
att de då också kände sig sämre till mods, sov sämre och hade förändringar i 
immunparametrar, bl.a. en markant ökning av regulatoriska T-celler. Stress gav också 
specifika förändringar hos de atopiska studenterna, bl.a. en förskjutning mot Th2 dominans, 
ökad ångest, och mer störd sömn jämfört med de icke-atopiska studenterna. Trots dessa 
förändringar rapporterades ingen ökning i allergiska symptom. 
Artikel III baseras på en prospektiv epidemiologisk studie (Twin Study of Child and 
Adolescent Development (TCHAD)), och data kommer från frågeformulär ifyllda av 
föräldrar kring olika aspekter av barns störda sömn och allergi. Studien replikerar tidigare 
fynd som visar att störd sömn och allergi samvarierar i hög grad. I en mer komplex modell 
som också kontrollerar för faktorer som kön, födelsevikt, socioekonomisk status och 
tidigare sömn- och allergiproblem, kunde vi dessutom se att övertrötthet hos barn (8-9 års 
ålder) kunde förutsäga förekomst av rinit i tidiga tonåren (13-14 års ålder), och att astma hos 
barn kunde förutsäga förekomst av övertrötthet i tidiga tonåren.  
Fynden från studie I-III visar att störd sömn är vanlig hos allergiker. Det behövs alltså 
behandling av sömnproblem för personer som också har andra komorbida problem, t.ex. 
allergi. Artikel IV är därför en randomiserad kontrollerad studie för behandling av insomni 
med komorbida problem, bl.a. allergi. Bedömningar med frågeformulär och sömndagbok 
gjordes före behandling, direkt efter behandling, och tre månader efter avslutad behandling. 
Studien visar att deltagare i behandlingsgrupperna får förbättrad sömn, och att allergikers 
sömn förbättras lika mycket som icke-allergikers, trots allergisymptom.  
Sammanfattningsvis visar studierna att stress kan vara en delfaktor som påverkar 
allergirelevanta immunförändringar hos atopiker, och den kumulativa negativa effekten av 
stress (s.k. allostatisk belastning) tycks vara förhöjd hos atopiker jämfört med icke-atopiker. 
Resultaten talar för att stress kan vara en faktor i utvecklingen av allergi och tvärtom, men 
visar också att störd sömn kan behandlas effektivt med hjälp av en KBT-baserad 
självhjälpsbehandling, också hos personer med allergi. Avhandlingen styrker ett samband 
mellan stress, sömn och allergi. Nya studier behövs för att visa om framgångsrik behandling 
av sömn eller stress kan minska förekomsten av allergiska symptom hos allergiker, eller 
t.o.m. minska risken att utveckla allergi. 
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